Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Group enriched"	"Detected in some"	110	"MOLT-4: 65.8;REH: 62.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043939			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043939: AB_2732512"	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	65.8	0.0	0.5	0.0	62.9	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5
OR5AK2		ENSG00000181273	"Olfactory receptor family 5 subfamily AK member 2"	Q8NH90	11	56988872-56989867	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"lymphoid tissue: 11.0"	"Cell line enhanced"	"Detected in single"		"AF22: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.2	11.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HIST1H3J	"H3/j, H3FJ"	ENSG00000197153	"Histone cluster 1 H3 family member j"	P68431	6	27890382-27893106	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"lymphoid tissue: 290.9"	"Cell line enhanced"	"Detected in many"		"U-266/84: 15.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.15e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.91e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.37e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-8)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.04e-2)"	0.9	0.4	0.2	25.1	0.3	5.7	1.1	0.5	0.4	1.2	5.5	0.0	0.0	0.3	0.4	0.5	9.4	0.4	1.2	0.9	0.4	0.4	0.3	1.2	1.5	8.8	0.4	0.0	0.3	0.4	0.3	0.3	4.7	0.0	0.6	0.3	0.0	0.4	0.6	0.3	1.6	3.7	0.3	1.1	15.1	0.6	2.4	0.0	290.9	0.9	7.8	14.6	1.1	1.1	2.1	2.5	0.0	0.7	0.6	2.5	0.7	1.0	0.7	1.6	0.3	0.5	0.5	0.9	0.0	0.0	1.5	0.2	0.0	0.4	4.7	0.9	0.4	0.2	1.3	0.4	0.0	0.2	0.9	1.1	1.9	0.0	0.4	0.2	0.3	0.0	0.0	0.7	0.0	0.7	2.6	1.1	0.0	1.1	3.6	4.3	2.5	0.4	1.6	0.5	0.5	0.0	0.0	2.8	1.6	1.8	1.2	0.0	0.4	0.8	0.0	0.4	0.0	0.2	0.4	3.5	15.1	1.1	0.8	0.6	2.4	0.0	0.0	0.0	1.4	0.3	0.0	0.0	2.3	2.5	2.5	2.1	0.5	1.0	0.0	0.6	0.7	0.0	2.2	0.7	0.2	0.3	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0
HIST1H3G	"H3/h, H3FH"	ENSG00000273983	"Histone cluster 1 H3 family member g"	P68431	6	26269405-26271815	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"lymphoid tissue: 247.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;SiHa: 10.1;U-266/70: 9.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.88e-1)"	"prognostic favourable (8.75e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.23e-2)"	0.7	0.4	0.0	14.6	0.0	1.9	1.7	0.0	0.0	0.5	5.2	0.0	0.0	2.1	0.1	2.2	9.1	1.5	0.8	1.1	0.0		0.2	0.0	1.0	7.3	0.0	0.0	0.1	0.0	0.3	0.0	4.8	0.0	0.1	1.6	0.0	0.4	0.4	0.0	0.3	4.7	0.4	0.0	13.6	1.0	5.0	0.0	247.1	1.0	8.0	15.9	0.7	0.0	1.6	0.4	0.6	0.4	0.2	1.5	0.7	1.1	0.2	1.1	0.0	0.1	0.2	0.5	0.4	0.2	1.2	0.4	3.9	0.0	0.0	0.6	0.1	3.3	1.3	0.6	0.8	0.9	0.0	0.1	2.5	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.3	0.3	0.0	2.3	0.0	2.4	1.1	0.4	2.0	0.0	0.8	0.0	1.4	0.7	0.7	0.3	0.6	10.1	3.1	0.0	0.1	0.5	0.3	0.5	0.0	0.0	0.2	9.6	0.3	0.0	0.5	0.0	1.2	0.0	0.0	0.3	0.3	0.1	0.4	1.1	1.5	1.0	0.4	1.6	0.0	0.5	0.6	0.2	0.4	0.0	1.5	0.7										
HIST1H2BE	"H2B.h, H2B/h, H2BFH"	ENSG00000274290	"Histone cluster 1 H2B family member e"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	26	"lymphoid tissue: 165.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.0;REH: 7.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.7	1.1	0.4	12.2	0.8	5.9	1.8	0.6	1.7	2.5	2.9	0.1	1.8	1.1	1.5	2.9	5.5	1.6	1.6	1.9	0.5		1.7	0.3	1.5	6.7	0.0	1.2	2.1	1.2	0.7	0.0	2.4	0.2	5.2	1.5	0.7	4.0	2.2	2.1	1.9	2.0	1.8	1.6	4.5	2.5	5.4	0.0	165.1	1.2	6.4	7.1	1.8	0.0	3.6	3.1	5.5	1.7	1.6	2.9	0.8	0.5	3.6	2.9	0.9	2.9	0.4	0.4	3.0	1.0	0.5	0.3	0.8	2.1	0.6	1.4	0.5	4.2	0.5	1.1	0.6	1.5	0.9	0.5	1.4	0.1	0.2	0.3	2.4	0.6	0.2	0.6	0.2	0.3	2.3	1.8	0.1	1.6	4.5	8.0	2.4	0.9	7.8	0.2	2.5	1.4	1.8	2.7	3.6	3.9	1.4	0.9	2.7	1.6	0.8	1.5	2.6	1.0	1.9	2.3	4.4	0.6	0.6	1.4	0.5	5.2	1.7	2.4	2.0	1.3	1.6	2.1	2.0	2.5	0.7	3.6	1.8	1.7	5.5	1.6	1.5	3.1	2.9	0.8										
HIST1H2BF	"H2B/g, H2BFG"	ENSG00000277224	"Histone cluster 1 H2B family member f"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"lymphoid tissue: 252.2"	"Group enriched"	"Detected in some"	4	"U-266/70: 21.3;U-266/84: 15.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.4	1.2	0.0	17.3	0.1	3.8	5.7	0.3	0.7	2.7	3.3	0.4	1.0	0.5	1.6	1.3	9.9	1.3	1.2	0.6	0.0		0.5	0.4	2.5	7.0	0.0	0.2	0.8	0.6	0.4	0.0	3.2	0.2	5.4	1.1	0.5	1.4	1.3	0.2	0.4	3.0	0.3	0.9	8.3	1.3	2.2	0.1	252.2	0.4	3.3	14.6	2.4	0.0	3.0	0.7	6.2	0.7	0.4	1.5	1.2	0.4	0.2	0.2	0.4	0.2	0.0	0.2	0.1	0.1	0.6	0.1	0.5	0.0	0.5	0.9	0.0	0.8	0.4	0.1	0.3	0.6	0.2	0.3	1.4	0.1	0.1	0.1	0.7	0.2	0.0	0.1	0.1	0.1	1.6	3.8	0.0	0.1	3.2	1.3	0.5	0.5	1.2	0.6	2.4	0.1	0.1	2.1	0.3	4.1	0.8	0.0	3.7	0.2	0.1	0.3	1.9	0.0	0.5	21.3	15.0	1.2	0.1	0.9	0.4	0.0	0.2	1.4	0.7	0.3	1.5	0.7	0.7	0.8	0.4	3.0	0.6	1.2	6.2	0.4	0.7	0.7	0.6	1.2										
HIST1H2AI	"H2A/c, H2AFC"	ENSG00000196747	"Histone cluster 1 H2A family member i"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 349.3"	"Cell line enhanced"	"Detected in many"		"K-562: 17.3;U-266/84: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	1.7	1.2	0.7	36.2	0.9	10.7	2.8	0.6	0.7	1.5	6.3	0.0	0.5	2.3	1.1	1.4	14.2	1.4	2.8	4.8	1.1	1.1	1.0	1.3	3.5	25.8	0.6	0.0	1.2	0.4	1.4	0.6	5.4	0.0	1.3	5.8	0.0	1.3	0.3	0.5	1.1	7.1	0.5	4.3	21.9	2.2	4.3	0.0	349.3	1.0	15.2	26.8	2.3	2.0	3.0	2.6	4.8	0.8	2.5	4.0	2.0	0.9	3.6	0.8	0.6	0.4	0.2	0.3	0.7	0.1	1.1	0.9	1.1	0.6	1.0	2.2	0.3	0.7	0.0	0.6	0.5	3.5	4.7	1.5	5.8	3.0	0.4	0.4	0.8	1.6	0.2	0.4	0.1	0.2	17.3	4.1	0.0	4.5	2.5	2.7	0.9	1.3	1.2	0.0	6.7	1.3	0.6	5.1	1.0	10.1	1.5	0.3	6.1	0.4	0.2	0.5	1.9	0.4	0.4	3.8	47.5	2.0	0.4	4.0	0.3	0.0	0.5	3.6	0.9	0.8	0.7	2.1	3.2	0.9	2.3	3.0	0.7	0.4	4.8	2.5	0.8	2.6	4.0	2.0	0.7	0.9	0.6	0.7	1.1	1.1	0.6	0.0	0.0	0.0
HIST1H2BH	"H2B/j, H2BFJ"	ENSG00000275713	"Histone cluster 1 H2B family member h"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 220.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 17.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.9	0.6	0.0	25.6	0.0	3.1	2.1	0.0	0.0	0.9	5.5	0.0	0.9	7.8	1.0	2.4	8.4	1.5	4.0	1.8	0.0		0.7	0.0	2.2	11.3	0.0	0.0	0.4	0.1	0.0	0.0	4.9	0.0	1.2	2.2	0.0	1.8	0.1	0.0	0.6	8.1	0.1	0.0	9.6	1.6	3.3	0.0	220.5	0.4	9.5	23.3	1.4	0.0	1.0	0.9	4.7	0.4	1.0	0.7	9.3	1.8	0.1	7.3	0.0	0.0	0.1	1.2	0.9	0.4	1.3	0.6	2.4	1.1	0.0	1.8	0.1	3.6	0.0	0.6	1.8	0.9	0.1	1.3	5.5	0.4	0.0	0.0	4.2	0.3	0.3	0.5	0.5	0.3	2.6	6.5	0.1	2.0	3.8	2.7	1.7	1.9	4.0	0.0	0.9	0.0	2.8	3.4	3.0	4.3	1.4	0.6	2.1	3.3	0.0	0.6	0.0	0.8	3.2	17.7	4.4	0.0	0.5	1.5	3.9	3.5	0.4	0.7	0.5	0.0	0.2	1.0	0.3	0.7	0.9	0.6	0.1	0.2	4.7	1.0	0.2	0.4	0.7	9.3										
LCE3B	LEP14	ENSG00000187238	"Late cornified envelope 3B"	Q5TA77	1	152613811-152614098	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	23	"lymphoid tissue: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HIST1H2AJ	"H2A/E, H2AFE"	ENSG00000276368	"Histone cluster 1 H2A family member j"	Q99878	6	27814354-27814740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 357.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.8;Karpas-707: 11.9;MCF7: 16.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"			HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.6	0.1	0.0	7.2	0.0	16.5	0.2	0.0	0.2	1.0	5.2	0.0	0.0	0.3	0.3	0.6	6.6	0.3	0.8	0.2	0.0		0.3	0.4	2.2	3.1	0.0	0.0	0.1	0.1	0.1	0.0	3.6	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.4	3.9	0.1	0.0	10.5	0.8	5.2	0.0	357.7	0.1	7.9	23.1	1.5	0.0	4.2	2.7	2.5	0.5	0.4	5.9	5.0	3.9	0.0	1.2	0.0	0.0	0.0	0.9	1.2	1.1	1.0	2.5	2.1	0.1	3.9	0.4	0.7	1.1	0.0	1.1	0.6	1.8	0.6	5.5	0.5	9.8	0.3	0.0	2.1	0.0	0.3	0.5	0.3	1.4	0.0	11.9	0.3	16.5	6.6	6.0	1.9	3.5	5.8	0.0	2.3	0.2	2.4	0.5	0.8	1.1	1.1	0.5	0.4	4.0	0.0	0.0	2.3	0.4	0.2	6.1	3.9	3.7	1.3	4.4	2.8	0.0	0.1	0.0	0.7	0.5	0.9	0.7	3.4	3.1	2.7	4.2	1.1	0.4	2.5	0.4	0.2	0.3	5.9	5.0										
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145568-19170289	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"lymphoid tissue: 81.2"	"Group enriched"	"Detected in some"	12	"Daudi: 49.8;U-266/70: 50.0;U-698: 65.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	2.0	1.0	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3.0	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1.0	0.6	1.8	2.9	2.0	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1.0	3.7	1.0	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3.0	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	49.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.3	0.0	0.9	0.4	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.4	0.5	0.1	50.0	4.6	65.8	0.1	0.3	0.0	0.0	0.9	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.4	1.0	0.6	1.1	0.9	1.0	0.8
HIST1H2BM	"dJ160A22.3, H2B/e, H2BFE"	ENSG00000273703	"Histone cluster 1 H2B family member m"	Q99879	6	27815044-27815424	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"lymphoid tissue: 232.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3;NB-4: 11.1;REH: 7.2;U-266/70: 13.4;U-698: 6.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.1	0.1	0.0	19.9	0.0	11.6	0.1	0.0	0.2	1.6	3.4	0.0	0.0	0.1	0.7	0.9	8.4	0.1	1.4	0.3	0.0		0.1	0.3	1.8	7.3	0.0	0.0	0.3	0.1	0.1	0.0	1.5	0.0	0.5	1.1	0.0	0.3	0.1	0.1	0.8	3.8	0.1	0.5	13.9	0.5	3.5	0.0	232.2	0.1	9.4	27.6	0.1	0.0	2.6	0.4	0.3	0.3	1.5	1.7	0.0	1.5	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.5	2.1	0.4	0.3	2.2	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.8	0.2	0.8	0.0	0.0	2.0	0.0	0.0	0.8	0.0	0.0	0.2	17.3	0.0	0.5	4.5	11.1	3.3	0.8	7.2	0.0	0.4	0.0	0.0	0.1	1.9	0.7	1.1	0.0	1.0	3.3	0.0	0.0	2.0	1.2	0.1	13.4	0.5	6.8	1.1	1.2	0.9	0.0	0.1	0.1	1.5	0.3	1.7	1.9	1.7	1.5	0.4	2.6	0.1	1.2	0.3	1.5	0.0	0.2	0.6	0.0										
HIST1H1B	"H1.5, H1b, H1F5, H1s-3"	ENSG00000184357	"Histone cluster 1 H1 family member b"	P16401	6	27866849-27867529	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 342.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.7;NB-4: 7.5;U-698: 5.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4"									"CAB012241, HPA055907"	Approved		Supported	Nucleoplasm		510000	510000	Nucleoplasm	Nucleoplasm	"CAB012241: , HPA055907: AB_2682966"	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.4	0.4	22.9	0.5	18.2	2.1	0.5	0.4	1.7	7.3	0.0	0.0	0.3	0.5	1.0	10.2	0.3	1.9	0.6	0.5	0.5	0.4	0.6	3.9	10.7	0.5	0.0	0.4	0.4	0.3	0.4	6.4	0.0	0.4	0.5	0.0	0.8	0.3	0.4	1.4	7.0	0.3	1.7	14.4	1.3	1.7	0.0	342.6	0.6	10.5	26.0	2.0	0.7	13.0	12.7	0.7	1.1	1.8	3.4	2.1	2.2	0.0	0.8	0.0	0.0	0.0	1.7	0.7	0.6	1.0	0.6	0.7	1.5	2.6	0.4	0.8	0.8	0.0	0.0	0.1	0.8	0.9	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.9	2.6	1.9	0.1	0.4	13.7	7.5	2.1	0.0	4.2	0.0	0.0	0.4	0.0	1.9	1.1	2.3	0.3	0.0	1.0	2.4	0.8	1.4	0.1	1.3	1.0	2.8	0.0	5.8	1.9	0.9	1.3	0.0	0.9	0.0	3.3	0.9	1.7	4.8	3.1	3.4	5.1	13.0	1.7	1.8	0.7	1.8	1.1	12.7	3.4	2.1	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.0
HIST1H2AG	"H2A.1b, H2A/p, H2AFP, pH2A/f"	ENSG00000196787	"Histone cluster 1 H2A family member g"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 305.4"	"Cell line enhanced"	"Detected in many"		"K-562: 9.7;SiHa: 11.2;U-266/84: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8"									HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	2.4	1.6	1.1	25.1	1.2	6.3	8.7	0.7	1.0	3.3	9.7	0.0	1.0	3.8	2.0	3.7	15.7	1.0	3.2	2.7	1.3	1.6	1.1	2.6	6.0	13.5	2.3	0.0	1.4	0.9	0.3	1.0	8.7	0.3	2.5	2.3	0.3	2.1	1.5	1.1	1.4	7.1	0.9	2.3	20.2	1.8	16.1	0.0	305.4	1.5	12.3	28.9	2.4	2.0	4.4	1.3	9.7	0.8	1.1	3.8	7.7	1.3	1.8	1.5	1.4	4.8	1.0	1.0	0.5	0.7	1.6	0.2	0.7	1.4	0.4	2.0	0.5	2.7	1.8	0.8	1.1	2.4	1.0	0.7	3.5	0.0	1.0	0.7	1.4	1.8	0.3	0.5	0.5	0.5	9.7	4.6	0.1	1.7	1.8	1.1	0.9	1.2	1.2	1.5	4.9	0.3	0.3	6.0	1.4	11.2	1.8	0.6	0.0	0.4	0.5	1.8	3.9	1.4	0.7	8.2	30.5	3.1	0.3	1.1	1.1	9.7	0.4	0.7	0.6	0.3	1.3	3.0	2.3	1.6	0.6	4.4	2.2	1.8	3.5	1.1	0.8	1.3	3.8	7.7	1.1	1.2	0.7	0.9	1.3	1.6	2.3	0.0	0.3	0.0
HIST1H2AK	"H2A/d, H2AFD"	ENSG00000275221	"Histone cluster 1 H2A family member k"	P0C0S8	6	27837947-27838339	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 115.7"	"Cell line enhanced"	"Detected in some"		"A549: 4.2;AN3-CA: 4.8;HeLa: 4.9;SCLC-21H: 4.7;U-266/84: 7.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA041189	Supported									"HPA041189: AB_2677357"																		1.5	4.1	0.0	11.1	0.5	3.2	3.5	0.9	1.3	2.8	2.3	0.2	0.5	1.0	1.7	1.6	4.4	2.7	4.1	2.5	0.0		0.2	0.4	4.4	8.4	0.8	0.0	3.3	0.0	0.0	0.1	1.7	0.3	2.3	0.4	0.9	1.7	1.1	0.7	0.0	1.5	0.3	1.6	7.0	1.3	3.9	0.5	115.7	1.6	2.8	12.3	2.1	0.0	6.0	1.2	0.0	0.6	1.1	3.8	5.1	0.0	4.2	0.0	4.8	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.4	0.0	0.2	0.2	0.8	2.1	1.0	0.0	0.5	1.3	1.2	1.7	4.9	0.6	0.7	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.6	0.4	0.0	0.9	0.3	4.7	0.8	0.0	0.0	0.0	0.5	0.0	0.2	0.5	0.5	0.0	0.3	1.8	7.0	1.0	0.0	0.3	0.5	0.0	0.1	0.0	2.3	0.0	1.8	5.8	2.6	2.4	0.0	6.0	3.8	2.8	0.0	1.1	0.6	1.2	2.7	5.1										
HIST1H3I	"H3.f, H3/f, H3FF"	ENSG00000275379	"Histone cluster 1 H3 family member i"	P68431	6	27871905-27872315	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 236.8"	"Cell line enhanced"	"Detected in some"		"HEL: 4.5;MOLT-4: 8.2;NB-4: 5.5;REH: 8.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0"					"Cell type enhanced"	"Detected in many"		"NK-cell: 12.4"	"Low lineage specificity"	"Detected in all"											HPA042570	Approved									"HPA042570: AB_2678056"		"unprognostic (1.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.48e-2)"		"unprognostic (2.39e-1)"		"unprognostic (1.18e-1)"				"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.29e-2)"	1.0	0.8	0.0	16.7	0.0	7.9	2.4	0.0	0.4	0.9	2.9	0.0	1.6	0.4	0.4	1.4	7.1	0.5	2.9	1.8	0.0		0.4	0.4	1.9	9.2	0.0	0.0	0.4	5.0	0.4	0.0	2.4	0.0	0.5	0.4	0.0	1.0	0.7	0.4	0.4	3.6	0.4	0.0	10.2	0.8	1.8	0.0	236.8	0.6	11.6	14.5	0.4	0.0	4.1	4.7	1.0	1.2	12.4	2.4	2.2	1.2	1.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.2	2.9	0.4	0.0	0.9	0.0	0.0	0.5	1.3	1.7	4.5	0.0	0.0	1.0	2.7	0.6	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	5.5	1.2	0.0	8.6	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.2	0.5	2.4	0.6	2.0	0.8	2.0	1.5	3.3	4.1	1.7	2.2	1.0	12.4	0.5	4.7	1.9	2.2										
HIST1H2AL	"dJ193B12.9, H2A/i, H2AFI"	ENSG00000276903	"Histone cluster 1 H2A family member l"	P0C0S8	6	27865355-27865747	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 288.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.1;MOLT-4: 8.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	1.1	0.5	0.0	24.8	0.0	16.4	1.3	0.0	0.5	1.1	4.5	0.0	0.0	1.1	0.8	1.7	7.6	0.3	1.8	1.5	0.0		0.4	0.4	3.4	10.2	0.0	0.0	0.3	0.3	1.5	0.0	5.2	0.0	0.3	0.3	0.0	0.7	0.3	0.3	0.5	4.4	0.3	0.0	12.9	0.7	13.1	0.0	288.3	0.3	9.6	26.4	0.5	0.0	9.6	4.7	8.8	3.6	0.1	2.0	1.1	4.1	1.7	0.8	0.0	0.0	0.0	1.1	1.7	0.7	1.4	1.6	0.0	1.4	3.1	1.1	0.0	1.2	0.0	0.0	0.4	3.1	7.1	1.2	0.0	1.1	0.0	0.8	1.5	0.0	0.0	0.4	0.0	0.0	5.4	3.2	0.4	3.7	8.7	6.3	2.9	1.3	4.5	0.0	0.4	0.6	2.6	2.0	2.0	1.2	0.0	0.8	0.4	1.2	0.0	0.2	0.0	1.4	2.9	5.5	0.0	6.3	1.4	4.0	1.3	2.4	2.0	1.3	0.1	1.7	0.0	3.3	1.7	2.0	4.7	9.6	0.7	1.0	8.8	0.1	3.6	3.4	1.7	1.1										
HIST1H2BI	"H2B/k, H2BFK"	ENSG00000278588	"Histone cluster 1 H2B family member i"	P62807	6	26272976-26273356	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 150.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 5.3;MOLT-4: 14.8;THP-1: 6.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.5	0.1	0.0	19.0	0.0	8.9	1.2	0.4	0.1	1.3	3.1	0.0	0.5	0.1	0.7	2.1	6.6	0.4	2.0	1.3	0.0		0.3	0.1	2.0	6.3	0.0	0.0	0.7	0.1	0.1	0.0	2.8	0.0	0.1	0.3	0.0	1.3	0.3	0.1	1.2	1.9	0.1	0.1	11.1	0.4	1.9	0.0	150.8	0.4	8.2	14.5	2.2	0.0	4.7	0.7	0.9	1.3	0.4	4.6	0.2	1.8	0.8	1.2	0.0	0.0	0.0	0.2	0.7	0.7	2.0	5.3	0.8	0.0	0.9	0.4	0.4	0.9	1.8	0.5	0.8	2.6	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.8	0.0	3.8	0.0	0.7	14.8	2.5	2.8	0.0	4.0	0.0	4.9	0.0	0.4	0.3	0.9	1.1	1.0	0.0	0.0	6.2	0.9	0.8	0.0	0.6	3.0	3.1	0.4	0.0	1.1	0.5	2.2	0.2	0.5	0.0	3.4	1.3	2.2	2.2	3.2	4.6	0.7	4.7	1.4	0.8	0.9	0.4	0.1	0.3	1.5	0.2										
HIST1H2BO	"H2B.2, H2B/n, H2BFN"	ENSG00000274641	"Histone cluster 1 H2B family member o"	P23527	6	27893463-27893843	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 164.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 28.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favourable (4.89e-4)"	1.9	0.4	0.0	14.9	0.0	8.1	1.5	0.0	0.0	0.9	3.9	0.0	0.0	0.9	0.6	1.6	9.9	0.0	0.7	1.5	0.0		0.3	0.5	2.6	7.4	0.0	0.0	0.0	0.0	0.7	0.0	4.4	0.1	0.3	1.5	0.0	1.2	0.0	0.3	1.5	2.1	0.1	0.5	8.1	0.7	1.4	0.0	164.5	0.0	7.1	15.4	1.1	0.0	2.6	2.2	6.5	0.8	1.3	1.7	5.5	2.2	2.9	1.4	4.3	0.7	0.0	2.6	0.8	0.1	5.3	5.3	1.1	1.3	2.5	1.9	0.2	2.2	2.4	0.5	0.7	1.7	1.9	1.6	4.4	1.7	0.0	0.2	1.0	0.3	0.0	0.4	0.5	1.4	6.4	7.2	0.2	0.5	10.9	9.3	1.6	2.1	6.4	1.5	4.8	0.9	0.3	6.1	1.3	4.6	1.2	0.7	2.0	0.2	0.0	1.5	0.3	1.7	2.0	8.0	28.8	7.4	0.9	9.3	0.7	1.3	0.3	3.8	0.8	0.6	1.1	1.4	0.8	1.7	2.2	2.6	0.5	0.5	6.5	1.3	0.8	1.7	1.4	5.5										
HIST1H3F	"H3/i, H3FI"	ENSG00000277775	"Histone cluster 1 H3 family member f"	P68431	6	26250195-26250605	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 198.6"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.3;U-266/84: 9.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"											"HPA042570, CAB070190"	Approved									"CAB070190: AB_10001790, HPA042570: AB_2678056"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.91e-6)"		"unprognostic (9.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"		"unprognostic (2.14e-1)"		"unprognostic (1.00e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-4)"	1.1	0.9	0.0	26.8	0.0	8.0	3.9	0.0	0.2	0.5	4.5	0.0	0.2	1.5	0.7	2.4	8.6	0.4	2.2	4.2	0.0		0.3	0.2	2.5	17.0	0.0	0.0	0.2	0.2	0.2	0.0	3.8	0.0	0.4	0.4	0.0	0.8	0.2	0.7	0.7	4.6	0.5	0.0	10.8	1.1	2.8	0.0	198.6	0.4	11.5	25.3	0.9	0.0	4.5	1.3	0.0	0.6	0.0	0.9	0.4	1.4	0.0	2.2	0.0	0.0	0.0	1.6	1.3	0.0	2.5	0.7	0.0	0.0	0.2	1.1	0.0	0.9	0.0	1.1	0.0	1.4	0.5	1.6	4.5	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	1.3	2.4	1.8	0.0	1.8	3.4	8.3	0.0	2.4	3.8	0.0	1.2	0.0	0.3	4.3	1.0	1.6	0.8	0.0	3.2	2.8	0.0	0.4	0.0	0.2	1.9	2.2	9.4	0.0	2.5	3.0	1.0	0.0	0.5	0.0	0.5	0.0	0.1	4.5	0.1	0.0	1.3	1.3	0.3	0.0	0.0	0.0	0.6	0.0	0.9	0.4										
HIST1H2BL	"dJ97D16.4, H2B/c, H2BFC"	ENSG00000185130	"Histone cluster 1 H2B family member l"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 217.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.9;U-266/84: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	1.2	1.0	0.2	13.9	1.0	13.7	1.6	1.4	0.6	1.8	5.1	0.0	0.3	0.6	0.8	0.6	7.4	0.9	0.9	1.3	0.9	0.7	0.3	0.6	1.5	3.5	0.5	0.0	1.3	1.2	1.2	0.2	1.9	0.0	1.2	1.1	0.0	0.7	0.2	0.2	0.9	3.9	0.7	2.8	4.8	0.8	1.5	0.0	217.6	1.2	5.9	15.6	1.1	1.2	1.9	1.2	7.7	0.6	0.4	2.0	0.9	2.4	2.2	0.7	2.3	0.0	0.0	0.1	1.4	0.4	1.2	3.2	1.0	1.7	0.9	0.5	0.3	1.5	0.0	0.2	0.4	1.1	3.2	1.7	3.1	3.8	0.0	2.8	2.3	1.0	0.0	0.0	0.0	0.7	2.2	5.7	0.0	6.0	12.9	4.8	2.1	3.3	3.0	0.0	1.4	0.0	2.2	3.0	1.1	3.9	1.6	0.2	1.4	0.9	0.5	0.1	1.6	1.3	1.0	3.3	12.7	4.2	0.4	5.0	0.5	0.6	0.5	4.0	1.1	0.2	1.3	1.9	0.6	1.1	1.2	1.3	0.4	0.6	7.7	0.4	0.6	0.7	2.0	0.9	0.2	1.0	1.4	0.5	0.9	0.7	0.5	0.0	0.0	0.0
HIST1H4L	"H4.k, H4/k, H4FK"	ENSG00000275126	"Histone cluster 1 H4 family member l"	P62805	6	27873199-27873510	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 133.0"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 10.0;NB-4: 5.4;REH: 2.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.2"					"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.7"	"Low lineage specificity"	"Detected in many"											HPA042201	Approved					30000000	30000000			"HPA042201: AB_2677898"										"unprognostic (1.15e-1)"				"unprognostic (6.05e-4)"				0.4	0.3	0.0	23.6	0.0	4.6	2.8	0.0	0.3	0.4	3.0	0.0	0.5	0.3	0.3	0.3	3.4	0.3	1.2	0.5	0.0		0.3	0.3	1.2	4.2	0.0	0.0	0.3	8.4	0.3	0.0	2.5	0.0	0.3	1.0	0.0	0.5	0.3	0.3	0.3	2.2	0.3	0.0	11.5	0.8	4.0	0.0	133.0	0.3	7.6	16.4	0.3	0.0	7.7	3.8	0.0	1.8	1.7	1.9	0.6	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.0	5.4	0.0	0.0	2.6	0.7	0.0	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	1.0	0.0	1.3	0.8	0.3	1.8	1.1	1.9	2.6	7.7	0.5	1.4	0.0	1.7	1.8	3.8	1.3	0.6										
SPIC	"MGC40611, SPI-C"	ENSG00000166211	"Spi-C transcription factor"	Q8N5J4	12	101475421-101486997	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 74.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.1;non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.1"	"Not detected"	"Not detected"																		"unprognostic (9.82e-2)"	"unprognostic (2.43e-2)"					"unprognostic (9.03e-3)"	"unprognostic (2.51e-1)"		"unprognostic (4.85e-2)"			"unprognostic (5.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.77e-1)"			0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.1	4.7	0.1	16.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.3	0.0	0.1	74.6	0.1	0.1	0.0	3.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	4.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HIST2H3A	"H3/n, H3/o"	ENSG00000203852	"Histone cluster 2 H3 family member a"	Q71DI3	1	149852619-149854274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 126.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;SiHa: 8.3;U-266/70: 7.3;U-266/84: 7.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"											HPA042570	Approved									"HPA042570: AB_2678056"					"unprognostic (1.15e-1)"					"unprognostic (1.30e-1)"				"unprognostic (3.99e-2)"				1.3	0.9	1.3	22.4	2.0	4.6	2.1	5.0	3.6	0.5	4.4	0.0	0.0	1.2	0.5	1.5	6.6	0.9	1.3	1.9	1.3	0.6	0.4	1.0	1.6	5.9	0.7	0.0	0.3	2.4	0.2	0.7	4.5	0.0	2.4	0.3	0.0	1.3	0.3	0.6	0.9	2.9	0.2	1.1	6.1	1.5	2.1	0.0	126.9	0.4	8.5	12.6	0.7	0.7	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.2	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	2.6	0.0	0.1	0.2	0.8	5.5	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.1	2.5	3.1	0.1	2.2	1.5	2.0	1.7	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.3	2.3	0.4	1.4	1.8	0.0	0.6	4.7	0.3	0.4	7.3	7.2	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2	1.3	2.0	5.0	1.1	1.3	0.6	0.7	0.0	0.0	0.0
HIST1H2AB	"H2A/m, H2AFM"	ENSG00000278463	"Histone cluster 1 H2A family member b"	P04908	6	26033176-26033568	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 133.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.7	0.3	0.2	7.6	0.0	9.6	2.6	0.2	0.6	0.5	1.7	0.0	0.0	0.3	0.5	0.3	5.0	0.3	0.7	2.6	0.0		0.6	0.3	1.7	5.9	0.0	0.0	0.3	0.3	0.3	0.0	2.6	0.0	0.5	0.3	0.2	0.3	0.3	0.3	0.3	2.2	0.3	0.1	8.2	0.7	8.3	0.0	133.2	0.3	1.5	12.2	0.3	0.0	4.2	1.8	3.4	1.5	1.4	2.4	0.3	0.2	1.0	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.3	1.8	0.9	0.0	0.6	0.5	0.0	0.6	0.9	2.2	1.0	0.5	9.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.4	1.0	0.0	1.4	2.0	1.9	3.6	3.4	1.1	0.7	1.5	0.0	3.0	0.4	0.1	2.1	0.0	0.1	0.6	1.0	0.0	0.3	3.9	0.3	0.2	1.4	2.4	0.0	0.6	3.7	0.3	0.0	0.1	3.4	0.8	1.5	0.0	4.2	1.5	2.4	1.8	3.1	0.6	0.8	0.7	1.4	0.1	0.2	0.6	0.3										
HIST1H2AD	"H2A.3, H2A/g, H2AFG"	ENSG00000196866	"Histone cluster 1 H2A family member d"	P20671	6	26198851-26199243	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 225.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 20.7;U-266/84: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.0"	"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	2.6	1.8	0.9	13.8	1.1	14.7	6.3	0.8	1.3	8.0	4.6	0.0	3.2	1.5	2.0	3.1	9.2	1.3	2.8	5.5	1.2	1.3	2.3	3.6	4.8	15.9	1.1	0.5	3.4	1.9	1.1	1.5	4.6	1.0	6.8	2.2	1.5	2.5	4.3	1.2	3.2	4.3	2.3	3.6	10.8	1.8	5.7	0.6	225.6	1.4	5.1	14.3	5.3	8.6	7.0	5.7	16.0	1.8	1.1	3.8	0.8	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.3	1.9	0.0	2.4	0.3	0.0	1.6	0.3	0.4	0.0	0.3	0.2	0.1	1.3	0.2	1.5	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.4	1.6	0.0	0.1	2.9	1.3	1.6	0.3	1.5	0.5	1.5	0.3	0.1	1.5	0.3	0.7	1.4	0.1	0.5	0.5	0.0	1.5	4.0	0.0	1.1	20.7	6.7	2.5	0.8	1.8	0.7	2.2	0.2	3.2	1.1	1.8	1.1	2.0	1.5	3.8	1.0	7.0	1.4	1.1	16.0	1.1	1.3	5.7	2.0	0.8	0.9	1.1	0.8	1.3	1.2	1.3	1.1	0.5	1.0	0.6
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 242.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 19.5;RPMI-8226: 10.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4"	"Group enriched"	"Detected in many"	39	"B-cells: 5.4;T-cells: 2.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favourable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.9	0.5	0.9	0.9	0.9	0.0	3.6	0.9	0.9	2.0	3.3	0.9	0.9	2.3	0.9	9.3	3.6	3.3	2.1	0.9	0.9	0.0	1.4	0.9	2.4	0.9	0.9	0.9	1.2	17.1	6.4	1.8	2.1	0.9	1.8	4.1	0.9	4.3	2.5	0.9	2.9	2.8	0.9	0.9	0.9	3.9	0.9	0.9	242.8	8.7	0.9	0.9	2.0	1.1	5.4	0.0	0.0	0.0	0.0	2.3	0.4	2.9	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	3.4	4.5	0.0	0.7	0.0	1.5	2.5	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.9	0.5	0.0	19.5	0.0	4.0	0.0	2.2	1.8	0.0	1.1	0.4	0.0	0.6	0.5	0.0	0.0	10.5	2.3	3.4	0.0	0.0	1.3	3.0	0.0	1.9	0.8	0.0	0.0	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	2.0	5.4	2.3	1.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
HIST1H2AH	"dJ86C11.1, H2A/S, H2AFALii"	ENSG00000274997	"Histone cluster 1 H2A family member h"	Q96KK5	6	27147129-27147515	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 301.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 8.9;MOLT-4: 9.2;NB-4: 10.0"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.2"	"Low lineage specificity"	"Detected in many"											"CAB004030, HPA041189"	Supported									"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.8	0.7	0.0	26.0	0.0	20.2	1.5	0.0	0.4	3.1	6.6	0.0	0.6	1.0	1.8	2.6	6.4	1.0	2.7	1.3	0.0		0.5	0.4	4.1	5.4	0.0	0.0	2.4	0.5	0.4	0.0	9.0	0.0	0.6	0.9	0.1	1.7	0.6	0.4	0.6	6.5	0.9	0.0	13.9	0.7	23.5	0.0	301.1	0.6	9.0	27.3	1.9	0.0	16.2	2.2	0.0	2.4	5.1	4.7	2.3	2.5	3.4	1.1	4.8	0.0	0.0	0.7	0.3	0.6	0.6	0.0	2.6	1.0	3.7	0.9	0.0	0.3	1.0	0.0	0.0	2.1	8.9	4.6	3.0	0.0	0.0	3.2	1.7	0.0	0.0	1.1	0.0	0.8	4.7	2.4	0.9	0.4	9.2	10.0	3.1	1.2	3.4	3.0	4.9	0.0	0.3	2.4	0.6	1.4	0.5	0.2	0.9	1.5	0.0	0.8	2.7	0.2	2.7	2.9	2.9	6.0	1.3	4.5	0.8	0.0	0.9	0.0	2.6	2.4	1.2	3.8	4.7	4.2	2.2	16.2	2.4	1.6	0.0	5.1	1.5	1.5	0.8	2.3										
HIST1H2BN	"H2B/d, H2BFD"	ENSG00000233822	"Histone cluster 1 H2B family member n"	Q99877	6	27837760-27865798	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	13	"lymphoid tissue: 193.3"	"Cell line enhanced"	"Detected in many"		"K-562: 8.7;SCLC-21H: 9.6;U-266/84: 9.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	2.4	7.2	2.3	14.0	3.3	9.3	3.1	4.9	6.2	3.4	4.5	1.0	4.4	1.8	3.4	3.7	7.6	3.2	3.7	6.4	3.7	2.4	2.3	5.3	5.4	8.0	4.1	4.2	5.0	8.3	4.2	3.8	4.5	1.4	4.0	2.5	1.7	3.3	4.7	4.6	2.3	4.3	2.5	9.4	7.0	2.4	6.8	0.5	193.3	6.1	6.2	10.9	3.6	2.2	6.0	6.2	14.6	2.6	1.0	2.8	1.4	1.4	0.2	1.5	1.5	1.2	1.9	0.9	0.7	1.1	0.7	0.8	0.5	0.8	0.7	3.0	0.7	2.1	1.3	0.4	0.3	1.5	4.4	0.7	3.6	1.3	1.4	0.9	3.6	1.2	0.3	0.1	1.3	0.2	8.7	6.8	0.8	1.8	2.9	4.4	1.3	1.0	2.0	0.9	5.1	0.4	0.9	9.6	1.9	3.5	1.3	2.9	2.4	0.8	1.5	2.1	2.1	1.1	0.6	6.0	9.0	3.5	0.7	1.7	0.7	2.3	2.6	1.7	2.6	2.4	1.8	5.8	2.0	1.9	5.0	6.0	1.3	1.2	14.6	1.0	1.8	6.2	2.8	1.4	2.3	3.3	4.9	6.2	3.7	2.4	4.1	4.2	1.4	0.5
HIST1H3B	"H3/l, H3FL"	ENSG00000274267	"Histone cluster 1 H3 family member b"	P68431	6	26031650-26032060	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 343.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 11.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (2.82e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-7)"	"unprognostic (8.52e-2)"	"unprognostic (2.78e-1)"		"unprognostic (1.90e-3)"	1.7	0.7	0.0	36.1	0.0	18.1	3.6	0.0	0.3	0.8	6.9	0.0	0.0	0.3	0.8	2.5	11.8	0.5	1.9	2.4	0.0		0.6	0.3	3.4	10.4	0.0	0.0	0.3	0.3	0.3	0.0	7.8	0.0	0.3	0.8	0.0	1.0	0.3	0.3	0.3	6.3	0.8	0.0	14.7	0.5	26.9	0.0	343.5	0.8	18.2	27.7	0.3	0.0	0.8	0.1	1.2	0.0	0.0	1.4	3.1	1.8	4.6	1.3	4.0	0.0	0.4	0.0	0.2	0.8	0.7	0.7	1.1	1.0	3.0	2.0	0.3	0.7	1.6	1.2	1.7	2.0	4.4	3.2	5.9	1.3	0.0	2.4	2.1	2.9	0.0	0.6	0.0	1.0	6.5	5.9	1.1	0.9	7.3	7.4	3.1	3.2	4.3	2.9	8.4	0.5	0.0	2.0	1.7	5.1	1.6	0.5	2.8	1.5	1.4	1.3	4.1	0.7	1.7	9.5	11.9	3.9	3.4	4.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.1	0.5	0.0	0.2	1.2	0.0	0.0	0.0	1.4	3.1										
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042167-23044276	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 32.7"	"Cell line enriched"	"Detected in single"	4	"PC-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Region enriched"	"Detected in single"	7	"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced									"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	32.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 188.8"	"Cell line enriched"	"Detected in single"	1104	"MOLT-4: 110.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"myeloid DC: 16.3"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 16.3"									HPA021824	Approved									"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.8	0.1	0.2	1.9	0.2	0.0	0.6	0.2	0.2	0.8	0.6	0.3	0.2	0.0	0.3	0.2	0.9	0.7	1.3	0.2	0.2	0.0	0.6	0.3	1.7	4.0	0.2	0.2	0.3	0.3	0.0	0.2	0.2	0.2	0.2	5.6	0.2	0.6	0.2	0.2	6.2	0.8	0.3	0.2	1.9	0.9	0.2	0.2	188.8	0.4	0.4	2.4	0.5	0.8	0.0	16.3	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
HIST1H2AM	"H2A.1, H2A/n, H2AFN"	ENSG00000278677	"Histone cluster 1 H2A family member m"	P0C0S8	6	27892757-27893149	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 315.3"	"Cell line enhanced"	"Detected in many"		"U-266/84: 24.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	1.2	1.5	0.0	30.7	0.0	9.3	2.3	0.2	0.2	2.1	6.1	0.1	2.3	1.4	1.3	2.6	10.7	0.3	3.9	2.2	0.0		0.6	1.7	4.7	12.7	0.0	0.0	0.4	1.2	0.0	0.0	10.4	0.3	0.9	1.8	0.0	1.3	2.2	0.7	1.0	6.5	0.0	1.1	15.3	1.7	4.8	0.0	315.3	1.3	11.4	28.9	2.5	0.0	10.3	14.7	28.7	6.2	4.8	8.5	7.0	3.1	2.7	2.1	5.0	0.3	0.3	4.4	0.9	0.7	2.6	3.4	1.0	1.3	5.3	3.6	0.7	2.2	1.6	1.7	1.6	3.4	1.3	2.7	3.4	3.5	0.0	1.6	2.2	1.3	0.0	1.8	0.0	2.5	11.4	7.3	0.4	5.2	10.7	7.7	3.7	1.2	6.6	3.5	9.4	1.3	0.7	8.0	1.4	5.5	0.6	0.6	4.8	1.6	0.0	1.1	0.1	1.2	1.6	7.9	24.7	12.3	1.5	9.3	0.9	28.7	3.4	12.5	6.8	3.8	4.1	8.9	5.9	5.7	11.4	10.3	2.5	2.8	11.5	4.8	6.2	14.7	8.5	7.0										
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"lymphoid tissue: 169.5"	"Cell line enhanced"	"Detected in many"		"HEL: 16.5;MOLT-4: 30.5;WM-115: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 4.7;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	3.4	5.9	3.3	3.2	7.9	3.5	3.1	9.3	8.0	3.9	3.5	2.4	3.2	3.5	3.6	5.2	3.7	2.5	2.2	4.6	2.8	2.2	3.7	4.3	5.1	6.1	2.4	2.6	14.0	2.5	5.3	4.2	3.0	2.3	2.7	1.6	3.7	2.7	3.1	3.3	3.0	3.6	4.5	2.5	3.3	2.7	14.8	2.2	169.5	2.3	2.2	4.3	4.7	2.7	0.8	0.0	0.1	0.1	4.7	2.3	1.6	2.5	5.0	1.6	2.3	1.2	2.2	9.8	0.4	0.6	1.3	0.7	2.2	2.1	0.0	2.2	0.8	7.3	1.3	1.2	0.5	0.1	1.6	16.5	2.9	5.9	0.8	0.6	3.5	1.1	2.2	1.7	1.4	2.6	3.7	0.2	1.6	1.6	30.5	3.4	1.9	2.2	8.8	0.1	6.3	2.4	2.7	1.5	0.5	3.6	3.0	2.4	0.6	1.8	7.6	1.9	2.2	3.1	2.8	0.5	0.5	11.7	4.8	1.2	14.7	0.0	0.0	0.1	2.3	0.0	0.2	0.4	0.6	1.7	0.0	0.8	1.5	1.4	0.0	4.7	0.1	0.0	1.1	1.6	3.3	7.9	9.3	8.0	2.8	2.2	2.4	2.6	2.3	2.2
AL031777.3		ENSG00000282988			6	26195595-26199293	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 184.8"	"Cell line enhanced"	"Detected in some"		"K-562: 7.8;SiHa: 7.4;U-2 OS: 5.6;U-266/70: 9.4;U-266/84: 6.1"									"Cell type enriched"	"Detected in many"	4	"neutrophil: 18.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.7"									HPA041189	Uncertain									"HPA041189: AB_2677357"																		1.3	1.3	0.1	10.9	0.2	13.1	4.8	0.3	0.7	3.9	3.4	0.0	2.2	0.7	1.0	2.2	7.1	1.2	1.9	4.2	0.0		1.0	1.1	3.5	12.7	0.0	0.1	2.4	1.2	0.7	0.0	3.4	0.4	2.9	0.9	0.9	1.1	3.2	0.7	0.7	3.2	1.5	2.6	8.5	1.7	4.3	0.1	184.8	0.9	3.9	11.4	4.0	0.0	2.7	1.1	18.7	1.0	0.6	1.1	0.7	0.8	0.5	0.2	0.7	0.2	0.1	0.0	0.7	0.1	1.4	0.4	0.6	0.9	0.8	2.4	0.0	1.2	0.3	0.0	0.0	2.6	0.3	0.7	2.4	1.5	0.0	0.2	0.8	1.1	0.0	0.8	0.5	0.2	7.8	1.6	0.0	1.1	2.8	1.7	0.2	2.3	0.7	0.2	4.3	0.0	0.0	0.9	0.2	7.4	0.0	0.5	4.7	0.0	0.8	0.8	5.6	0.0	0.2	9.4	6.1	0.9	0.5	2.2	0.3	4.3	0.0	1.2	0.3	0.3	0.4	0.9	0.6	0.6	0.4	2.7	0.5	0.8	18.7	0.6	1.0	1.1	1.1	0.7										
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689567-34691277	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 418.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;Daudi: 2.5;HDLM-2: 7.5;HL-60: 1.9;TIME: 3.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"intermediate monocyte: 2.3"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.3"					"Low region specificity"	"Detected in many"			HPA067758	Enhanced				"Secreted to blood"					"HPA067758: AB_2685897"	"prognostic favourable (2.88e-5)"	"prognostic favourable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	22.5	0.6	1.2	82.3	1.1	0.0	10.2	0.8	1.3	5.8	4.7	1.5	1.5	1.0	1.5	5.9	16.3	3.4	10.4	16.5	0.8	0.7	11.8	12.8	13.6	418.9	2.1	1.0	3.4	1.7	0.0	2.0	0.6	1.5	7.0	11.0	7.4	23.1	1.0	0.7	8.7	40.2	4.5	2.2	8.2	9.0	2.8	0.6	73.1	14.9	9.9	90.9	13.4	2.3	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	7.5	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.7	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	1.1	0.8	1.3	0.8	0.7	2.1	1.0	1.5	0.6
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 308.0"	"Cell line enriched"	"Detected in single"	1338	"MOLT-4: 167.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"myeloid DC: 29.7"	"Lineage enriched"	"Detected in many"	13	"dendritic cells: 29.7"					"Low region specificity"	"Detected in all"			HPA057769	Uncertain				"Intracellular and membrane"					"HPA057769: AB_2683522"	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	1.0	0.2	0.7	2.8	0.7	0.0	1.1	0.7	0.7	1.5	1.0	0.7	0.7	1.2	0.9	0.7	7.0	1.9	3.9	0.7	0.7	0.2	2.0	0.7	2.4	4.7	0.7	0.7	0.7	0.8	0.0	0.7	0.7	0.7	1.8	4.8	0.8	1.9	0.8	0.8	11.5	2.1	0.8	0.7	3.8	3.1	0.9	0.7	308.0	1.0	1.3	8.1	2.4	2.7	0.0	29.7	0.0	2.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.1	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.7	0.7	0.7	0.7	0.2	0.7	0.7	0.7	0.7
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favourable (2.75e-5)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	2.5	0.1	3.3	5.5	1.8	7.4	0.0	3.5	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4
HIST1H3C	"H3.1, H3/c, H3FC"	ENSG00000278272	"Histone cluster 1 H3 family member c"	P68431	6	26045411-26045821	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 306.0"	"Cell line enhanced"	"Detected in many"		"U-937: 10.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.27e-2)"	1.7	0.2	0.0	23.3	0.0	12.8	1.8	0.0	0.7	1.0	5.1	0.0	0.0	1.2	0.5	1.5	10.1	0.4	1.6	1.8	0.0		2.8	0.6	3.0	10.9	0.0	0.0	0.2	0.4	0.2	0.0	6.6	0.0	0.6	1.1	0.0	1.0	0.2	0.2	0.7	5.4	0.2	0.0	18.8	1.0	29.9	0.0	306.0	0.2	9.9	25.2	2.3	0.0	2.2	1.0	0.3	0.2	3.3	3.7	1.9	2.6	0.6	1.3	0.0	0.6	0.0	0.0	2.0	0.9	5.0	5.1	0.0	0.4	0.0	0.1	0.5	1.2	0.0	0.5	3.5	3.6	0.4	4.1	0.5	3.6	0.4	2.6	1.7	0.0	0.4	1.4	0.0	1.6	0.0	0.0	0.0	0.0	4.0	5.1	2.3	5.0	4.6	0.0	0.0	0.6	5.5	0.1	1.6	5.0	3.2	0.5	1.3	1.5	0.0	0.0	0.0	2.1	3.4	2.3	0.1	0.0	1.5	10.9	3.5	0.0	0.2	0.0	1.5	0.1	0.0	1.5	0.6	1.1	1.0	2.2	0.6	2.2	0.3	3.3	0.0	0.9	3.7	1.9										
CCL22	"A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1"	ENSG00000102962	"C-C motif chemokine ligand 22"	O00626	16	57358772-57366190	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 89.8"	"Cell line enriched"	"Detected in some"	18	"HDLM-2: 32.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (2.67e-2)"	"unprognostic (7.68e-3)"	"prognostic favourable (2.98e-4)"	"prognostic favourable (2.23e-6)"	"unprognostic (8.87e-2)"	"prognostic favourable (9.17e-5)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.88e-2)"	10.5	0.6	0.3	27.7	0.5	0.3	1.9	0.2	0.3	1.6	1.3	0.0	0.4	1.0	0.6	0.5	4.6	0.4	2.6	0.4	0.3	0.3	0.6	0.5	4.6	11.9	0.3	0.0	0.3	0.9	0.0	0.3	0.2	0.1	0.7	5.4	0.1	5.9	0.2	0.3	7.1	7.4	0.7	0.3	5.5	1.1	0.3	0.0	89.8	0.7	5.9	31.8	3.6	1.6	3.1	2.6	3.7	0.8	1.4	0.7	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.9	0.0	0.0	0.1	32.4	0.1	0.1	0.2	0.3	0.0	0.1	1.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.1	1.2	0.0	1.8	0.2	0.1	0.1	1.4	0.0	0.2	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	3.6	0.8	0.6	0.6	0.4	0.4	3.1	0.5	0.4	2.6	1.6	0.6	0.7	3.7	1.4	0.4	1.0	0.4	0.5	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.0	0.1	0.0
HIST2H4A	"H4/n, H4F2, H4FN, HIST2H4"	ENSG00000270882	"Histone cluster 2 H4 family member a"	P62805	1	149832659-149839767	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 56.4"	"Cell line enhanced"	"Detected in many"		"SiHa: 27.0;U-2 OS: 24.1;U-266/70: 22.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Approved					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.90e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.78e-4)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.99e-2)"	1.5	2.3	0.8	10.5	1.9	4.6	1.7	3.8	2.0	3.7	2.9	0.8	0.6	1.9	2.0	1.5	4.1	5.9	4.3	3.5	1.0		1.9	0.2	1.8	4.7	0.8	1.2	3.0	5.5	0.0	1.4	2.5	1.9	6.4	0.0	0.9	2.9	3.4	0.4	0.0	3.2	1.8	0.7	4.9	1.7	3.5	0.5	56.4	4.8	5.1	7.0	5.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.2	1.0	3.2	3.8	1.2	1.4	1.4	1.2	4.9	2.3	3.6	4.8	1.1	5.3	0.5	8.6	0.0	3.2	0.1	6.8	10.2	1.2	13.7	1.3	3.5	1.2	1.1	5.6	4.2	1.6	2.5	0.8	5.5	12.3	0.2	16.4	4.4	2.9	4.3	6.9	3.8	2.5	10.1	0.5	1.2	17.6	5.1	27.0	2.6	4.1	11.3	2.3	0.0	2.3	24.1	3.1	2.5	22.5	19.0	6.5	2.3	3.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ITGAD	"ADB2, CD11d"	ENSG00000156886	"Integrin subunit alpha D"	Q13349	16	31393312-31426505	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 25.4"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.1;NK-cell: 2.6"	"Group enriched"	"Detected in many"	19	"NK-cells: 2.6;T-cells: 1.1"	"Low region specificity"	"Detected in many"							HPA026786	Uncertain									"HPA026786: AB_10603773"	"unprognostic (2.79e-2)"	"unprognostic (2.39e-4)"	"unprognostic (2.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.44e-4)"	"unprognostic (6.99e-3)"	"unprognostic (6.89e-3)"	"unprognostic (5.02e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.51e-2)"	0.3	0.1	0.1	1.0	0.1	2.5	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.2	0.0	0.4	0.2	0.2	0.2	0.1	0.1	0.1	1.2	0.7	4.0	0.1	0.0	1.6	0.1	0.0	0.1	1.2	0.0	0.1	0.0	0.2	1.5	0.0	1.3	0.1	0.3	0.0	0.2	25.4	0.1	0.2	0.0	0.4	0.1	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	2.6	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 92.0;MOLT-4: 21.5;REH: 25.7;T-47d: 20.6;THP-1: 39.3;U-937: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"CAB056144: AB_10584780, HPA051769: AB_2681600"	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favourable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.7	3.6	0.3	0.7	2.5	0.6	2.1	0.1	4.7	0.9	0.0	0.8	0.0	9.6	1.1	1.2	92.0	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.6	0.8	0.0	0.1	0.6	0.1	5.1	0.4	0.0	21.5	6.8	3.9	0.3	25.7	1.3	0.9	1.0	3.2	1.2	7.3	0.0	0.8	0.0	20.6	39.3	0.3	2.7	1.7	1.2	0.7	0.2	0.0	2.0	2.2	20.7	1.2	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114711-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 326.1"	"Cell line enriched"	"Detected in many"	15	"MOLT-4: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2"	"Group enriched"	"Detected in many"	19	"NK-cells: 14.2;T-cells: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB019403: AB_2199302, HPA058863: , HPA070505: AB_2686275"	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	1.8	3.6	1.3	21.8	1.5	5.2	3.1	0.9	1.2	2.1	3.3	2.5	2.2	5.6	1.4	16.3	2.7	16.1	2.6	1.6	1.5	1.2	2.7	3.7	4.0	41.8	1.3	1.0	2.5	7.2	0.2	6.1	1.4	4.7	2.9	2.3	3.6	7.9	1.8	0.9	2.9	15.1	0.9	3.3	14.4	3.7	2.4	1.1	326.1	4.4	2.2	32.5	3.3	1.5	1.2	0.1	1.0	0.1	14.2	35.8	6.9	0.0	1.0	1.1	3.8	0.5	2.1	1.5	0.3	0.5	0.1	0.1	7.9	2.5	0.0	1.9	1.7	0.1	1.7	0.4	0.0	0.3	1.6	0.0	1.0	5.9	0.0	0.0	0.2	0.1	0.0	1.6	0.0	0.2	1.0	0.0	0.1	0.0	166.9	0.1	1.2	1.4	0.2	0.0	0.1	0.4	0.1	0.4	3.3	0.8	0.2	0.2	0.2	0.9	0.2	10.8	0.0	4.9	0.3	0.1	0.0	0.0	5.7	0.0	0.5	0.7	0.1	1.0	4.4	0.0	10.3	1.2	17.8	10.4	0.0	0.4	35.8	21.8	0.7	14.2	0.0	0.1	2.1	6.9	1.3	1.5	0.9	1.2	1.5	1.2	1.3	1.0	4.7	1.1
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830914-157898256	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 178.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;Karpas-707: 1.9;REH: 2.0;RH-30: 1.2;U-266/70: 3.5"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"							"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	6800000000	6800000000			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		0.2	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	21.3	0.2	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	178.3	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.8	0.0	2.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144663-79175315	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 73.8"	"Cell line enriched"	"Detected in some"	7	"MOLT-4: 41.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA041025	Enhanced		Uncertain	Vesicles				Vesicles	Vesicles	"HPA041025: AB_10794260"	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	2.2	0.5	0.4	20.3	0.4	2.6	1.3	0.3	0.4	2.4	5.1	0.0	0.5	2.1	1.6	0.9	2.6	0.9	1.9	1.0	0.4	0.4	1.9	1.7	8.2	16.6	0.5	0.0	1.0	0.7	0.0	1.1	0.3	0.2	1.7	2.0	1.6	3.8	0.1	0.5	0.7	9.1	0.2	1.0	21.0	2.2	0.5	0.0	73.8	2.5	1.6	28.1	5.1	1.8	4.0	1.8	6.0	9.1	6.5	8.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	41.8	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	6.0	0.0	4.7	5.7	3.4	1.7	4.0	7.5	8.6	0.1	3.9	6.1	6.8	0.4	6.5	9.1	1.8	7.6	2.7	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.0	0.2	0.0
HIST1H3D	"H3/b, H3FB"	ENSG00000197409	"Histone cluster 1 H3 family member d"	P68431	6	26196840-26197250	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 185.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 7.9;U-266/70: 11.2;U-266/84: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (8.64e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.78e-6)"	"unprognostic (2.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	1.2	2.7	0.6	18.3	0.6	24.3	1.5	2.0	1.3	4.4	4.1	0.0	3.0	2.9	1.0	3.0	8.0	1.2	2.3	1.3	1.2	0.9	2.3	3.1	2.5	8.0	0.8	0.7	4.3	1.0	1.0	1.6	2.6	0.3	6.4	1.2	0.7	3.3	4.3	1.0	1.6	3.8	1.4	2.4	9.2	2.2	12.4	0.0	185.6	1.4	5.9	19.9	3.2	6.8	8.9	3.4	15.3	1.8	1.6	6.6	0.5	0.9	0.2	0.0	2.1	0.0	0.5	0.9	0.0	0.5	0.3	2.5	3.5	0.2	2.1	2.1	0.3	0.6	0.2	0.5	0.0	2.9	0.8	0.0	1.7	0.0	0.1	0.7	1.1	0.4	0.4	0.0	0.0	0.3	0.3	7.9	0.0	1.6	2.2	4.0	0.3	1.1	2.5	0.0	1.2	0.0	0.3	0.1	0.0	0.0	2.0	1.0	0.4	2.9	0.0	0.0	3.9	0.0	1.6	11.2	6.1	0.7	2.0	1.7	0.9	8.9	1.4	3.3	2.5	0.8	6.6	5.5	1.6	2.0	3.0	8.9	1.5	2.6	15.3	1.6	1.8	3.4	1.9	0.5	0.6	0.6	2.0	0.6	1.2	0.9	0.8	0.7	0.3	0.0
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309836-177362943	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 70.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.5;HL-60: 28.8;Karpas-707: 37.9;MOLT-4: 29.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065761			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.5	0.4	0.2	7.4	0.2	9.3	0.7	0.1	0.2	0.8	1.5	0.1	0.1	1.5	0.5	0.1	5.6	0.2	0.3	0.5	0.2	0.2	0.4	0.4	0.9	5.1	0.2	0.1	0.3	0.2	0.0	0.2	1.6	0.2	0.2	2.1	0.2	0.8	0.1	0.2	3.4	1.7	0.5	0.7	1.5	0.8	3.5	0.3	70.8	0.2	1.1	5.0	0.7	1.3	0.2	0.3	0.8	0.0	1.6	1.6	0.2	7.0	5.9	6.3	3.1	0.7	1.3	3.1	8.8	3.2	9.8	5.8	2.1	6.2	7.8	1.3	2.3	3.3	6.6	3.5	14.2	26.5	4.3	5.4	4.6	5.6	0.2	28.8	3.7	0.1	0.2	10.1	2.2	3.7	5.5	37.9	6.3	3.1	29.2	11.1	2.9	4.3	5.9	4.3	2.5	2.5	0.9	4.9	3.4	4.4	5.1	2.4	4.1	7.5	1.7	5.9	4.6	3.0	8.8	2.6	1.7	12.4	3.9	10.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.2	0.0	1.1	0.8	1.6	0.0	0.3	1.6	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.3
ARL5C	ARL12	ENSG00000141748	"ADP ribosylation factor like GTPase 5C"	A6NH57	17	39156894-39167484	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 21.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;MOLT-4: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.7"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.7"	"Low region specificity"	"Detected in many"							HPA069849	Uncertain									"HPA069849: AB_2686213"	"unprognostic (2.57e-1)"				"unprognostic (2.34e-1)"								"unprognostic (1.60e-7)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-2)"			0.2	0.2	0.2	0.2	0.6	0.0	0.6	0.2	0.5	1.3	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.6	0.2	0.1	0.4	0.1	1.5	0.2	0.0	0.1	3.0	0.0	0.1	0.7	0.4	0.1	0.2	0.8	0.1	1.1	0.3	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	21.1	0.1	0.0	1.3	1.2	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.6	0.2	0.5	0.6	0.2	0.2	0.0	0.4	0.0
CCR9	"CDw199, GPR-9-6, GPR28"	ENSG00000173585	"C-C motif chemokine receptor 9"	P51686	3	45886504-45903177	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 130.2"	"Cell line enriched"	"Detected in single"	324	"MOLT-4: 48.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 17.5;naive B-cell: 9.2;T-reg: 5.7"	"Group enriched"	"Detected in many"	42	"B-cells: 17.5;T-cells: 5.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB006839	Uncertain									"CAB006839: "	"unprognostic (3.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.88e-3)"	"unprognostic (4.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-3)"	0.1	0.1	0.1	1.8	0.1	0.7	0.1	0.1	0.3	0.1	2.2	0.1	0.1	7.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.2	0.1	10.7	0.1	0.2	2.2	0.3	0.1	0.1	130.2	0.1	0.1	0.7	0.1	0.1	17.5	0.2	0.0	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.5	2.2	1.8	0.2	9.2	0.3	0.1	0.0	0.0	0.0	0.2	5.7	1.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.5"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.6	1.2	2.0	13.7	2.4	7.0	3.0	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3.0	1.8	3.2	1.0	2.4	2.0	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5.0	1.9	2.4	1.1	2.3	4.0	1.7	3.0	5.0	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3.0	5.2	2.6	7.0	1.4	49.1	1.5	5.1	10.8	2.3	2.0	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.7	7.1	16.3	11.5	1.8	1.3	11.5	6.8	5.7	9.8	12.1	17.0	9.0	14.1	2.6	2.1	8.5	9.3	3.6	11.8	8.7	7.0	8.6	4.4	6.5	0.5	14.7	9.3	1.0	1.4	7.0	2.0	4.4	12.5	12.8	5.6	4.8	22.7	10.7	11.5	13.4	17.8	11.3	4.5	4.2	6.4	7.4	8.9	9.4	11.9	2.2	9.2	6.3	1.8	3.8	11.7	4.8	12.9	6.5	7.3	21.1	3.2	14.1	4.9	0.0	0.0	0.9	0.2	0.0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0.0	0.4	0.1	2.0	2.4	6.2	3.8	2.5	2.2	2.9	5.0	1.7	1.4
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304396-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 171.0"	"Group enriched"	"Detected in some"	420	"MOLT-4: 48.7;REH: 168.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"naive B-cell: 1.2;naive CD4 T-cell: 4.5"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036532: , HPA044194: "								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.1	0.1	0.3	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.7	0.0	171.0	0.6	0.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	168.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0
HIST1H2BB	"H2B/f, H2BFF"	ENSG00000276410	"Histone cluster 1 H2B family member b"	P33778	6	26043277-26043657	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in some"		"K-562: 3.6;Karpas-707: 3.5;MOLT-4: 4.4;NB-4: 4.8;THP-1: 5.4;U-266/84: 5.9"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.4	0.3	1.0	6.4	0.3	6.6	0.6	0.5	1.0	0.5	1.0	0.0	0.0	1.1	0.4	0.5	4.1	0.6	0.3	1.0	0.2		0.8	0.3	1.7	3.0	0.1	0.4	0.3	0.5	0.3	0.0	0.9	1.0	0.3	0.3	0.2	0.3	0.3	1.3	1.0	0.8	0.3	0.8	5.8	0.5	15.8	0.1	104.9	0.3	4.8	7.4	0.3	0.0	2.1	10.5	4.2	1.1	0.2	3.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.3	1.1	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	1.3	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.6	0.0	1.4	3.6	3.5	0.0	0.0	4.4	4.8	2.1	2.0	2.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.3	5.4	0.0	0.3	0.3	0.3	0.9	0.8	5.9	0.0	0.7	1.7	1.3	4.2	1.1	0.8	1.5	0.1	3.9	2.1	3.9	1.6	3.3	1.6	2.0	0.8	3.6	0.2	0.4	10.5	2.9	0.6										
HIST1H4D	"H4/b, H4FB"	ENSG00000277157	"Histone cluster 1 H4 family member d"	P62805	6	26188765-26189076	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 71.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 9.7;RT4: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.8"	"Low lineage specificity"	"Detected in many"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.77e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.11e-3)"	1.4	4.7	1.9	10.1	5.2	6.5	5.6	1.2	4.5	3.9	3.1	0.0	4.5	0.9	3.3	3.5	8.3	6.5	2.0	4.6	1.4		1.6	1.8	1.6	3.5	0.0	4.4	6.5	5.8	0.9	1.3	4.2	1.6	6.0	2.1	1.4	1.4	2.7	0.9	0.9	2.3	2.2	1.6	4.1	2.2	9.8	0.8	71.3	5.3	4.8	9.5	5.5	0.0	6.8	0.6	1.3	0.9	0.2	2.3	0.7	1.3	2.1	1.5	0.0	2.7	0.0	0.8	1.3	0.4	3.6	1.8	3.4	0.8	6.7	0.4	0.0	0.9	4.4	0.7	1.1	0.5	9.7	0.9	6.6	2.4	0.0	0.7	0.2	0.0	0.0	0.5	1.4	3.1	1.7	1.2	0.0	3.4	2.4	3.9	2.3	0.7	0.7	0.0	0.8	0.9	15.6	0.7	0.4	1.4	0.6	0.9	1.2	0.5	0.0	0.5	4.3	0.5	1.7	1.5	1.8	0.0	1.0	1.6	1.0	0.1	0.9	0.0	0.9	0.1	0.6	1.4	2.3	0.5	0.6	6.8	0.3	0.6	1.3	0.2	0.5	0.1	0.1	0.7										
RAG2		ENSG00000175097	"Recombination activating 2"	P55895	11	36575574-36598279	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 165.8"	"Group enriched"	"Detected in some"	90	"MOLT-4: 15.4;REH: 61.7"	"Cancer enriched"	"Detected in single"	21	"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA065704			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065704: AB_2732737"				"unprognostic (4.30e-2)"					"unprognostic (9.09e-2)"	"unprognostic (1.21e-1)"		"unprognostic (1.77e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.68e-3)"		0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	165.8	24.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	61.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (9.17e-5)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.1	9.9	27.3	11.6	1.4	3.8	22.3	26.6	11.7	35.5	26.4	21.6	23.7	35.1	7.2	14.0	12.9	34.3	15.7	29.2	16.8	15.8	28.2	13.2	21.0	0.3	42.4	20.0	0.9	1.2	14.6	8.8	21.2	40.0	35.3	28.1	13.7	54.0	24.6	21.5	11.1	24.8	52.8	17.1	10.0	7.6	11.6	12.3	14.0	17.1	7.4	14.3	18.0	12.4	16.6	25.2	17.5	25.4	22.4	23.7	40.2	9.5	43.2	18.4	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 53.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.6"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (2.88e-8)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	1.2	0.9	0.2	12.1	0.2	3.5	3.0	0.2	0.2	1.3	3.5	0.4	0.3	5.3	0.9	1.5	8.5	0.1	1.2	1.5	0.2	0.3	0.8	0.7	1.4	8.2	0.3	0.0	0.5	0.7	0.0	0.3	3.1	0.3	0.5	3.2	0.1	1.7	0.0	0.3	4.5	3.6	0.8	0.3	4.9	1.8	7.8	0.0	53.7	0.4	9.2	10.0	1.3	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	30.8	7.1	11.1	6.1	0.8	1.8	9.2	9.6	7.3	13.0	11.1	5.1	10.1	9.3	6.2	3.4	9.1	9.9	5.1	12.8	27.5	9.6	15.7	3.2	8.6	0.2	9.1	17.5	0.1	0.6	5.1	7.1	6.7	12.7	19.2	10.2	10.4	13.1	14.0	9.9	13.1	15.6	19.8	10.2	5.7	1.4	9.5	9.5	9.2	10.2	7.5	6.1	9.7	4.7	8.0	20.3	9.5	15.8	19.2	19.0	37.9	3.9	18.8	15.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.0	0.3	0.0
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 97.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.1;MOLT-4: 11.5;RPMI-8226: 4.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 13.3;naive B-cell: 16.2"	"Lineage enriched"	"Detected in many"	9	"B-cells: 16.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB002659, HPA052942, HPA060715"	Enhanced					150000000	150000000			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favourable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	0.5	0.3	0.4	97.2	0.3	0.0	0.4	0.3	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	2.8	0.3	0.3	0.3	0.4	0.4	1.4	0.4	2.0	72.8	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.0	6.0	0.0	0.4	0.3	11.5	0.0	0.4	63.4	1.4	0.5	0.0	6.5	0.7	0.3	56.3	0.6	0.3	16.2	0.0	0.2	0.0	0.0	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	11.5	0.0	1.9	0.2	0.0	0.2	4.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	13.3	0.7	0.5	0.0	16.2	1.8	1.6	0.2	0.0	0.0	0.0	0.0	1.1	0.4	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.0	0.0
HIST1H4F	"H4, H4/c, H4FC"	ENSG00000274618	"Histone cluster 1 H4 family member f"	P62805	6	26240426-26240737	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 118.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.8;MOLT-4: 11.0;REH: 5.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"										"unprognostic (1.47e-1)"				"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"			1.2	0.5	0.0	8.8	0.0	7.1	0.5	0.0	1.7	0.9	1.3	0.0	1.8	0.5	1.2	2.2	5.9	0.5	1.4	1.8	0.0		1.2	0.5	2.1	4.5	0.0	0.0	0.6	0.5	0.5	0.0	4.1	0.0	0.6	1.0	0.1	0.5	0.5	0.5	0.5	1.3	0.5	0.0	9.3	0.8	18.9	0.0	118.4	3.1	3.7	19.1	2.4	0.0	7.9	7.9	14.8	3.6	2.2	5.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.8	11.0	1.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	4.3	3.9	2.8	3.2	6.2	4.9	5.1	4.6	7.9	4.3	2.7	14.8	2.2	2.4	7.9	1.3	2.0										
HIST2H2AB		ENSG00000184270	"Histone cluster 2 H2A family member b"	Q8IUE6	1	149887524-149887916	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 126.3"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.8;U-266/70: 4.8;U-266/84: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	2.4	1.6	1.2	6.4	1.6	21.1	2.9	2.6	2.4	6.8	2.6	0.6	0.6	1.2	1.9	1.6	5.1	1.5	2.2	1.5	1.4	1.3	1.6	1.8	4.2	3.0	1.2	1.9	7.4	3.0	2.2	1.4	2.3	0.0	4.2	2.0	3.9	1.9	1.9	2.5	4.7	2.9	4.0	2.7	4.8	1.9	2.1	0.1	126.3	1.7	2.1	9.0	7.1	2.4	10.2	4.3	11.6	2.0	4.3	4.5	0.8	1.3	0.0	0.7	0.7	0.0	0.0	1.1	0.9	0.0	0.0	1.4	0.0	0.9	0.8	0.5	0.0	1.0	1.0	0.0	0.0	0.3	1.5	0.0	0.8	0.7	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	1.0	1.1	0.7	0.0	7.8	3.3	0.9	1.7	1.6	0.5	1.3	0.0	0.5	2.3	1.0	2.2	0.0	0.1	0.2	3.4	0.0	0.9	3.3	0.0	0.7	4.8	5.2	1.4	2.0	0.3	0.6	1.3	1.6	0.8	2.7	2.0	2.7	3.8	4.5	4.0	2.3	10.2	2.7	2.7	11.6	4.3	1.9	4.3	2.6	0.8	1.2	1.6	2.6	2.4	1.4	1.3	1.2	1.9	0.0	0.1
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391536-33409924	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 60.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	0.9	0.8	0.0	18.0	0.3	9.6	1.5	0.0	0.5	1.7	5.7	0.1	0.3	3.0	0.9	1.6	10.1	0.5	2.2	0.8	0.0	0.0	0.7	0.7	2.2	6.3	0.1	0.2	1.5	0.3	0.2	0.2	3.6	0.4	0.6	2.5	0.6	1.7	0.1	0.4	3.3	4.2	0.7	0.4	4.7	2.5	9.7	0.2	60.9	0.4	7.4	14.6	0.6	2.8	0.8	0.3	0.0	0.1	0.2	1.4	0.7	10.6	1.8	10.2	10.7	0.2	0.4	6.2	7.7	1.9	6.1	5.2	3.7	4.7	7.0	3.0	1.6	5.8	2.6	3.6	6.7	4.1	5.8	5.7	8.6	5.4	0.0	4.6	6.3	0.0	0.9	5.1	1.5	0.5	1.7	17.4	4.6	2.7	2.7	9.3	4.7	2.2	7.0	5.7	2.4	0.9	2.4	9.3	4.1	2.8	5.9	1.4	6.2	4.8	1.4	3.2	10.0	5.4	11.4	5.7	10.9	6.8	0.0	6.9	5.7	0.0	0.1	0.0	0.4	0.0	0.6	0.8	0.3	1.4	0.3	0.8	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.2
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in many"		"HL-60: 38.9;MOLT-4: 70.8;NB-4: 36.9;REH: 43.7;THP-1: 61.8;U-937: 33.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favourable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favourable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.8	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	24.8	0.1	0.0	0.0	38.9	19.6	0.0	0.0	0.1	0.0	0.0	20.1	3.7	0.2	2.0	70.8	36.9	0.2	0.3	43.7	1.0	6.0	0.0	0.2	1.9	1.2	0.0	1.9	0.0	1.4	61.8	0.0	0.0	0.3	1.4	0.4	4.7	1.2	12.0	0.0	33.7	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6
PSD4	"EFA6B, TIC"	ENSG00000125637	"Pleckstrin and Sec7 domain containing 4"	Q8NDX1	2	113157325-113209396	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"lymphoid tissue: 98.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.5;HMC-1: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA034722, HPA034723"	Approved									"HPA034722: AB_10669730, HPA034723: AB_2674299"	"unprognostic (1.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.13e-3)"	"prognostic favourable (9.91e-5)"	"unprognostic (6.56e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-2)"	"prognostic favourable (4.00e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.60e-3)"	5.2	11.7	2.6	53.9	3.7	6.2	5.5	0.8	2.1	2.3	5.6	2.9	2.3	5.9	2.6	4.7	8.5	1.9	8.1	3.6	2.6	1.6	3.9	16.2	14.1	25.9	3.1	1.9	2.2	9.5	11.1	3.0	2.9	2.8	6.9	4.4	3.0	11.6	2.5	1.6	6.7	13.6	2.1	2.4	29.3	8.4	1.5	3.4	98.7	8.4	2.5	40.4	4.7	3.1	4.8	7.0	14.2	3.7	7.1	6.4	5.2	7.7	0.5	0.5	0.0	0.0	0.0	14.6	1.0	3.2	0.5	0.4	0.7	9.8	20.5	1.5	0.5	6.9	0.0	2.4	0.1	14.1	0.0	13.3	0.3	4.6	0.3	16.8	25.7	0.0	2.4	0.3	0.4	0.0	9.9	8.7	0.0	5.9	16.6	16.6	0.3	1.3	0.2	0.0	11.1	0.2	3.4	0.6	0.0	0.6	10.3	0.0	3.4	15.2	0.0	0.1	0.2	0.1	2.4	9.2	5.4	8.1	0.4	11.7	0.0	1.7	3.3	3.6	6.3	2.6	6.2	4.8	3.4	6.4	3.9	4.6	3.8	4.3	14.2	7.1	3.7	7.0	3.3	5.2	2.6	3.7	0.8	2.1	2.6	1.6	3.1	1.9	2.8	3.4
SERPINA9	"CENTERIN, GCET1, SERPINA11b"	ENSG00000170054	"Serpin family A member 9"	Q86WD7	14	94462717-94479689	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 37.6"	"Cell line enriched"	"Detected in single"	64	"Daudi: 38.8"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.2"	"Region enriched"	"Detected in single"	18	"basal ganglia: 64.3"										"Secreted to blood"						"unprognostic (1.32e-2)"	"unprognostic (1.05e-1)"				"unprognostic (1.94e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.10e-2)"	"unprognostic (6.67e-2)"		"unprognostic (1.38e-2)"			"unprognostic (1.16e-1)"				0.1	0.1	0.1	37.6	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	1.8	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.6	0.2	20.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	6.0	2.7	0.0	0.1	0.6	0.1	0.1	0.0	0.4	0.3	0.3	36.0	0.1	0.2	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766727	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 71.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.7;HaCaT: 4.3;RH-30: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA026871	Enhanced		Supported	Cytosol		210000	210000	Cytosol	Cytosol	"HPA026871: AB_1857536"	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.6	0.2	0.1	0.5	0.1	0.4	0.5	0.1	0.1	0.7	1.4	0.1	0.1	0.1	1.1	1.1	2.5	0.9	0.6	0.4	0.1	0.1	0.1	11.7	0.5	19.9	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.2	0.5	0.2	0.1	2.1	0.3	0.1	0.2	0.3	0.2	0.1	71.3	0.3	1.5	0.1	0.2	0.7	0.5	0.4	0.3	0.4	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.7	0.2	0.0	0.0	15.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	4.3	0.0	0.0	0.0	0.0	1.1	0.4	0.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.1	2.5	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.6	0.8	0.4	0.0	1.1	0.2	0.2	0.0	0.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
AC010616.1		ENSG00000268041			19	41907705-41928516	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 5.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.5;HMC-1: 7.0;U-2 OS: 4.3;U-266/70: 3.8;U-698: 5.8;U-937: 4.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (1.97e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.88e-4)"	"unprognostic (3.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.21e-14)"	"unprognostic (5.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.98e-3)"	0.0	0.0		2.4		1.2	0.0		0.2	0.0	0.4			0.2	0.2	0.0	0.0	0.0	1.0	0.0			0.0	0.0	0.0	5.9			0.0	0.0	0.5		0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.6	0.0		2.2	0.8	0.7			0.0		2.4	0.0		0.1	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.1	0.7	0.3	0.0	0.3	0.2	0.3	0.2	0.0	0.8	9.5	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.4	7.0	0.1	0.4	0.4	0.2	0.0	0.3	0.5	0.0	1.0	0.0	0.0	0.0	0.3	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	4.3	0.2	0.0	3.8	0.2	5.8	0.2	4.1	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0										
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	19.8	11.1	18.1	11.0	1.0	2.5	6.8	15.9	11.2	15.8	12.5	7.7	15.5	20.3	5.7	12.4	20.1	15.5	6.3	19.7	18.2	11.8	14.2	26.2	7.4	0.2	21.2	10.1	0.2	0.6	12.7	8.9	16.6	17.8	24.1	16.2	7.8	17.0	9.9	8.2	3.0	13.0	24.8	14.9	5.7	5.5	9.5	13.5	22.6	11.7	5.1	13.0	8.8	12.6	9.8	9.5	16.8	28.9	6.9	9.4	11.7	7.7	5.8	19.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.4	7.8	8.7	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.8	3.8	14.1	2.6	1.1	9.1	13.4	3.7	6.1	8.5	9.9	14.7	8.4	2.2	0.0	14.1	7.3	0.0	0.0	4.7	2.4	3.3	12.7	4.4	4.9	3.4	10.6	7.8	9.3	1.7	10.8	16.4	5.4	1.1	9.8	6.5	6.1	3.3	4.4	2.6	3.1	11.6	1.8	3.4	6.3	3.5	8.7	3.2	13.1	14.7	1.9	10.0	5.8	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5
CARMIL2	"LRRC16C, RLTPR"	ENSG00000159753	"Capping protein regulator and myosin 1 linker 2"	Q6F5E8	16	67644919-67657569	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 47.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 22.1;MOLT-4: 21.6;REH: 36.4;RPMI-8226: 19.8;U-698: 36.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA041402	Approved									"HPA041402: AB_10795591"	"unprognostic (1.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.07e-2)"	"unprognostic (5.14e-10)"	"unprognostic (2.25e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.57e-2)"	0.7	0.6	5.8	23.0	6.4	5.5	0.3	5.9	7.4	0.6	2.0	0.4	0.3	1.9	0.6	1.0	1.9	0.3	2.4	0.5	10.0	3.9	0.9	0.3	1.8	24.4	2.3	0.4	0.4	3.0	0.1	2.8	0.5	0.6	0.5	0.8	0.5	6.1	0.7	0.5	0.4	8.0	0.5	0.7	12.9	1.9	0.7	0.4	47.7	0.4	0.5	21.6	2.5	0.3	1.5	1.1	0.0	0.0	1.7	2.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.5	0.2	0.0	0.2	0.0	3.3	0.2	22.1	0.4	0.0	0.0	2.1	0.0	0.0	4.9	2.8	1.3	0.1	0.4	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	21.6	10.9	3.8	0.1	36.4	0.0	19.8	0.0	0.0	5.6	0.6	0.0	0.0	0.1	0.1	0.6	0.0	0.3	0.7	0.0	0.1	6.4	11.1	36.8	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.7	0.9	2.7	0.7	0.1	1.5	0.8	0.5	0.0	1.7	0.0	1.1	2.5	0.4	5.8	6.4	5.9	7.4	10.0	3.9	2.3	0.4	0.6	0.4
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254137-158258269	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 105.1"	"Cell line enriched"	"Detected in single"	106	"MOLT-4: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4"	"Group enriched"	"Detected in many"	35	"B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9"									"CAB000009, HPA010734"	Enhanced									"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (7.21e-5)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.37e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.49e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.1	0.9	0.1	0.0	1.0	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.2	0.1	8.0	0.0	0.6	0.1	0.1	0.0	0.2	0.1	1.8	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.9	0.1	0.1	20.9	0.3	0.1	0.1	1.4	0.3	0.2	0.1	105.1	0.1	1.0	2.7	0.4	1.1	6.8	10.2	0.0	5.9	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.7	0.2	6.8	0.0	0.0	10.2	5.4	0.1	0.0	0.0	0.0	0.2	0.2	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304545-118316175	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 294.2"	"Cell line enriched"	"Detected in some"	77	"MOLT-4: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	36	"gdTCR: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8"	"Group enriched"	"Detected in many"	29	"NK-cells: 21.8;T-cells: 62.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced									"CAB000010: AB_2631163, CAB072863: , CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favourable (1.72e-4)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favourable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favourable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	3.9	1.0	0.5	16.7	0.7	6.8	1.9	0.5	0.7	2.1	4.7	0.9	0.7	4.4	2.0	1.4	3.3	3.0	4.0	1.4	0.5	0.5	3.3	2.6	7.3	40.9	1.3	0.6	1.5	1.3	0.0	0.9	1.2	0.9	2.6	3.9	1.9	6.4	1.1	0.8	1.3	21.1	1.1	1.9	34.5	4.6	1.2	0.5	294.2	3.4	2.1	37.8	6.3	3.0	0.2	0.9	1.4	0.2	21.8	62.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	118.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.5	0.0	0.1	0.0	1.3	0.2	0.2	59.5	0.1	50.2	0.1	50.7	55.7	0.1	0.2	61.3	62.0	1.4	21.8	0.2	0.9	46.8	32.9	0.5	0.7	0.5	0.7	0.5	0.5	1.3	0.6	0.9	0.5
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (1.10e-6)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.2	18.4	48.9	19.3	3.2	4.9	20.1	36.5	26.6	44.5	42.9	43.0	42.7	44.2	14.2	10.0	30.0	33.2	21.2	46.4	31.4	24.2	23.2	18.1	24.9	0.5	35.5	24.0	0.9	2.1	28.8	28.1	26.7	35.3	54.5	49.5	12.8	44.6	25.5	21.5	38.7	38.8	45.5	21.7	17.0	16.0	22.9	20.1	24.5	37.3	18.9	40.2	21.8	11.0	19.0	40.6	20.0	49.8	21.4	34.3	39.9	16.4	39.8	23.6	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell line enriched"	"Detected in many"	8	"BEWO: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	260000	260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoli fibrillar center, Cytosol"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavourable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	7.3	2.2	2.5	6.5	0.1	0.0	113.4	0.0	0.0	1.6	1.3	14.9	7.3	0.1	0.6	0.1	14.0	12.1	8.9	2.3	0.0	1.6	0.3	0.7	2.3	0.0	0.0	1.0	0.0	3.0	0.4	0.3	0.5	0.2	0.0	2.9	2.7	0.2	0.1	15.0	2.1	0.0	5.4	0.1	2.2	0.9	0.6	1.1	7.4	2.6	2.6	4.6	0.8	0.0	0.4	7.4	0.1	0.8	1.5	4.0	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0
CXCL13	"ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13"	ENSG00000156234	"C-X-C motif chemokine ligand 13"	O43927	4	77511753-77611834	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 82.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.4;RH-30: 1.2;U-266/70: 5.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.0"									HPA052613	Uncertain				"Secreted to blood"					"HPA052613: AB_2681885"	"unprognostic (5.25e-3)"	"unprognostic (1.19e-2)"	"prognostic favourable (9.12e-4)"	"prognostic favourable (5.52e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.41e-3)"	"unprognostic (9.82e-3)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (1.16e-10)"	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.68e-3)"	0.2	0.1	0.0	15.3	0.2	0.0	1.5	0.3	0.0	0.1	1.1			0.0	0.8	0.0	0.6	0.2	0.2	0.0	0.0	0.0	0.3	4.3	0.2	65.1	0.0		0.2	0.0	0.0	0.8	0.0		3.8	1.8		0.8	0.0	0.0	0.1	15.5	0.0	0.0	82.5	3.7	0.3			0.5		57.5	6.2	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	5.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021247-77065580	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 42.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"midbrain: 7.6;pons and medulla: 7.4;thalamus: 12.1"	HPA064866			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA064866: AB_2685374"	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	1.3	0.4	0.6	4.7	0.7	8.4	0.4	0.5	0.8	1.1	1.7	1.2	0.5	1.3	1.2	1.4	5.0	1.2	1.3	0.8	0.7	0.6	0.5	0.5	1.4	2.7	0.5	0.0	0.7	0.7	0.5	1.8	2.1	0.6	0.7	3.0	0.4	0.9	1.0	0.3	2.1	2.3	0.9	0.6	2.4	1.2	6.1	0.2	42.0	0.4	2.3	6.3	1.4	1.7	0.6	5.0	1.2	0.0	0.2	1.0	0.0	9.5	4.5	12.8	5.0	0.4	1.3	15.5	13.4	14.6	7.1	8.6	6.2	3.2	5.3	2.7	2.6	7.4	7.6	14.5	13.7	2.1	5.1	4.7	13.2	3.5	3.0	4.0	4.4	0.4	3.8	18.6	11.5	6.9	4.8	4.4	14.5	4.8	15.0	0.0	9.0	10.8	10.9	11.1	3.0	1.7	8.1	8.1	5.3	11.1	3.9	3.2	6.2	4.2	19.1	26.9	13.6	11.4	17.6	4.7	2.6	3.4	9.7	1.8	16.7	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	5.0	1.0	0.0	0.6	0.7	0.5	0.8	0.7	0.6	0.5	0.0	0.6	0.2
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127410	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 43.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.7;naive B-cell: 5.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	1.3	1.3	0.4	8.9	0.8	3.5	1.9	0.3	1.1	1.8	4.7	0.4	0.3	2.5	0.8	2.0	9.3	0.7	1.8	1.0	0.4	0.4	1.8	2.6	2.1	9.9	0.5	0.3	1.0	0.8	1.4	0.9	2.8	0.8	1.2	5.0	0.3	2.6	0.3	0.5	3.5	4.1	1.3	0.6	5.4	2.8	1.0	0.6	43.9	0.7	9.2	11.1	1.5	2.6	5.7	0.3	3.1	0.2	0.1	1.4	0.3	24.0	6.2	9.3	0.1	1.0	1.8	0.1	18.3	9.2	10.9	16.2	13.1	9.6	30.0	12.4	5.3	18.7	13.5	12.3	19.5	15.6	3.3	3.2	11.8	5.7	0.0	0.1	3.9	0.4	0.4	10.5	0.8	5.8	0.9	28.3	12.8	9.1	18.9	0.2	0.1	7.3	20.0	13.8	11.7	5.8	20.8	1.8	5.9	15.1	17.5	3.0	19.4	1.7	3.2	8.5	18.5	25.5	16.6	21.8	15.7	0.2	12.3	0.1	12.1	0.5	0.2	0.2	0.3	0.1	0.2	5.7	0.4	0.7	0.3	5.7	0.2	0.2	3.1	0.1	0.2	0.3	1.4	0.3	0.4	0.8	0.3	1.1	0.4	0.4	0.5	0.3	0.8	0.6
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet alpha subunit"	P07359	17	4932297-4935030	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 37.8"	"Cell line enriched"	"Detected in some"	24	"HEL: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	7	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					2000000000	2000000000			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.7	0.1	0.4	15.8	1.2	5.3	0.7	1.9	0.7	0.7	1.0	0.2	0.2	1.5	0.6	0.7	5.7	0.8	0.3	4.2	0.5	0.4	1.0	1.6	3.5	37.8	0.4	0.2	0.7	0.4	0.0	0.4	1.1	0.4	0.7	0.6	0.3	7.7	0.2	3.0	4.6	3.7	0.2	0.4	13.0	0.9	0.6	0.2	2.0	0.8	0.8	17.6	0.9	1.1	0.0	0.3	7.5	0.2	0.0	0.2	3.6	0.0	1.3	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.1	1.2	0.4	0.0	1.3	0.0	0.0	0.0	0.4	1.0	39.3	0.5	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.3	0.2	0.1	0.2	0.6	0.3	0.2	0.0	0.7	0.0	0.2	0.5	0.0	0.2	1.6	0.7	0.1	0.2	0.2	0.8	0.1	0.7	0.2	0.9	0.6	0.6	0.4	7.5	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.3	0.0	3.6	0.4	1.2	1.9	0.4	0.5	0.4	0.4	0.2	0.4	0.2
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdTCR: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		260000	260000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	18.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3
H2AFX	H2AX	ENSG00000188486	"H2A histone family member X"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 135.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: "	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	5.9	10.1	10.7	17.9	9.4	24.0	4.2	9.4	13.9	5.0	12.0	15.2	2.5	15.4	5.7	2.8	9.8	5.5	4.0	4.7	10.6	10.1	6.4	5.0	7.1	17.0	13.3	5.3	8.0	9.2	3.8	8.1	12.8	9.3	6.4	5.4	6.3	5.8	6.3	7.2	10.8	13.7	4.2	13.6	11.1	12.6	28.3	9.5	135.1	5.9	11.3	23.2	4.8	6.6	2.0	3.4	7.4	2.4	3.8	3.4	1.8	26.1	15.8	25.0	14.9	2.3	1.7	26.4	29.8	9.1	16.8	14.8	25.0	11.3	18.0	18.0	6.8	27.2	11.8	8.5	4.5	26.5	33.1	36.4	4.3	25.7	2.4	17.9	22.7	1.4	1.8	7.1	4.4	8.4	29.4	29.6	8.0	66.7	40.9	53.6	18.2	33.5	40.0	29.5	8.4	7.6	11.4	26.7	31.7	23.6	13.8	4.1	20.6	13.6	10.3	16.3	43.1	13.2	22.1	8.1	7.9	18.2	3.7	29.2	31.8	7.0	2.4	7.4	3.4	1.1	1.8	2.0	3.4	3.4	3.4	1.8	2.3	2.0	1.2	3.8	1.5	1.5	2.8	1.8	10.7	9.4	9.4	13.9	10.6	10.1	13.3	5.3	9.3	9.5
HIST1H1D	"H1.3, H1d, H1F3, H1s-2"	ENSG00000124575	"Histone cluster 1 H1 family member d"	P16402	6	26234268-26234933	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 182.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.4;MOLT-4: 13.3;NB-4: 6.1;REH: 5.5;SiHa: 5.4;U-266/70: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA055907	Supported									"HPA055907: AB_2682966"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.61e-8)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-2)"	3.2	1.1	0.4	14.7	0.9	37.5	5.0	2.8	0.9	4.1	5.2	0.1	2.0	1.0	3.9	4.8	10.7	1.3	3.7	2.5	0.8	0.8	1.5	1.1	9.9	21.2	0.6	0.0	3.4	0.9	0.9	0.6	2.3	0.1	3.7	2.4	1.4	1.8	1.0	0.9	6.1	4.9	1.2	4.4	14.2	1.6	4.6	0.0	182.1	1.7	4.5	17.6	8.3	9.2	26.3	17.9	8.6	3.8	12.5	21.2	8.0	1.0	0.7	0.2	0.0	0.4	0.0	8.4	0.4	0.3	1.1	0.8	0.2	0.9	0.0	0.2	0.1	1.0	0.3	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.2	0.3	0.4	2.3	2.3	0.1	0.0	13.3	6.1	0.7	2.5	5.5	0.1	3.1	0.0	0.0	2.8	0.4	5.4	2.3	0.0	1.1	1.3	0.0	0.4	0.0	0.2	0.9	6.9	3.4	0.4	1.0	1.8	0.7	8.6	3.8	3.2	17.7	2.4	12.6	16.5	16.3	12.0	9.5	26.3	21.2	16.4	1.4	12.5	3.4	17.9	12.1	8.0	0.4	0.9	2.8	0.8	0.8	0.8	0.6	0.0	0.1	0.0
HIST1H4A	H4FA	ENSG00000278637	"Histone cluster 1 H4 family member a"	P62805	6	26021679-26021990	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 87.7"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.6;NB-4: 9.9;REH: 12.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	4	"neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.0"									"CAB021887, HPA042201"	Supported					30000000	30000000			"CAB021887: AB_2279758, HPA042201: AB_2677898"	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.5	0.5	0.0	5.2	0.0	7.1	2.1	16.7	3.2	0.6	1.5	0.0	0.0	5.2	1.5	1.8	3.7	0.3	1.2	3.2	0.0		0.5	0.1	2.0	3.5	0.0	1.8	1.4	0.8	0.1	0.0	0.8	0.2	0.4	1.0	1.6	0.8	1.0	0.8	0.9	1.1	3.6	0.1	2.5	0.7	2.6	0.0	87.7	2.5	3.6	9.6	2.0	0.0	0.8	0.9	14.0	1.0	1.2	1.4	0.2	3.7	1.7	3.5	0.0	0.8	0.0	0.0	0.3	1.3	1.6	2.3	0.0	5.6	2.6	0.9	0.0	4.9	2.6	0.0	0.5	0.4	1.8	2.5	1.5	0.0	0.0	0.6	6.0	0.0	0.0	0.5	0.0	1.6	1.3	4.1	0.0	1.5	13.6	9.9	2.3	0.0	12.4	2.2	2.2	0.0	0.4	4.2	1.8	1.6	6.1	0.1	3.2	2.7	0.0	3.0	7.7	3.0	3.0	1.5	2.4	0.0	1.4	4.1	5.8	0.0	1.0	3.4	1.3	0.8	0.2	0.4	1.1	0.3	0.9	0.8	0.4	0.3	14.0	1.2	0.2	0.4	1.4	0.2										
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: , HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.5	0.6	4.5	3.0	0.3	7.7	4.0	5.9	5.2	0.3	2.2	0.4	0.6	4.4	1.3	0.1	0.5	4.6	1.2	0.9	0.4	1.5	0.0	6.6	0.2	1.7	5.4	0.0	7.6	1.9	3.3	1.2	2.3	0.8	0.9	3.1	3.7	0.4	1.0	0.3	1.1	0.7	2.8	0.4	2.6	7.2	4.1	3.5	0.3	1.3	9.6	1.4	1.5	0.0	11.2	2.0	31.4	1.0	1.3	5.2	0.3	3.3	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"HeLa: 4.2;Karpas-707: 1.1;SiHa: 3.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"													"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1										
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110675033	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 59.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.4;Karpas-707: 25.6;U-266/70: 18.5;U-266/84: 16.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 3.3;T-cells: 11.5"	"Low region specificity"	"Detected in all"							HPA016625	Approved									"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	1.9	1.3	4.0	7.8	5.7	5.6	1.3	5.0	5.6	1.7	3.1	0.5	0.0	3.2	1.1	0.4	1.1	1.3	2.3	1.4	3.5	4.3	1.5	1.3	7.8	14.5	1.5	3.1	1.3	0.9	0.4	1.8	0.9	3.1	1.1	2.6	0.5	3.7	0.3	0.5	0.8	5.9	0.7	1.9	7.7	5.3	1.4	1.5	59.4	2.1	0.3	10.9	5.8	1.3	3.3	1.0	0.0	0.7	0.9	11.5	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	5.3	0.0	0.5	0.0	0.0	0.0	5.1	0.0	0.0	3.6	0.3	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	18.5	16.6	6.4	0.0	1.5	0.0	0.0	0.7	0.0	7.2	0.0	8.2	2.3	10.8	11.5	1.0	3.3	8.5	6.4	0.0	0.9	0.1	0.5	9.5	2.9	4.0	5.7	5.0	5.6	3.5	4.3	1.5	3.1	3.1	1.5
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92593286-92655395	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 74.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"				Cytosol	Cytosol	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (8.19e-7)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	2.3	1.6	1.0	20.2	2.6	14.3	1.6	0.7	1.5	2.4	4.6	0.7	0.5	3.7	1.4	1.9	11.5	0.8	2.6	2.0	1.1	1.2	1.1	1.1	2.8	12.1	1.0	1.0	1.1	1.1	0.5	0.7	3.1	1.4	1.0	5.4	0.5	2.7	0.2	0.6	4.2	4.4	1.6	1.8	5.2	2.7	10.5	1.1	74.2	1.2	7.5	13.4	2.2	3.8	2.4	0.9	2.5	1.2	3.5	3.9	1.0	30.6	13.7	31.0	28.8	2.2	3.4	7.7	22.1	19.3	24.6	24.4	12.0	20.4	33.9	11.4	10.3	22.2	22.1	11.3	28.9	20.2	12.7	21.2	13.1	12.5	0.4	34.1	19.8	1.1	1.0	19.0	17.7	15.2	15.0	39.7	18.5	12.3	29.0	19.2	12.3	9.5	31.3	30.7	12.0	6.4	9.0	9.5	13.6	17.3	7.8	9.0	21.2	10.9	8.6	11.2	16.2	11.4	29.0	11.1	17.0	34.9	9.1	24.7	15.2	2.5	0.5	0.5	0.4	1.2	1.1	2.4	1.4	1.9	0.9	1.0	0.5	0.7	1.4	3.5	0.4	0.4	3.9	1.0	1.0	2.6	0.7	1.5	1.1	1.2	1.0	1.0	1.4	1.1
LCE3A	LEP13	ENSG00000185962	"Late cornified envelope 3A"	Q5TA76	1	152622834-152623103	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 50.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;LHCN-M2: 3.5;U-138 MG: 4.0;U-87 MG: 1.4"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 26.6;melanoma: 9.8"					"Cell type enriched"	"Detected in single"	33	"plasmacytoid DC: 3.3"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 3.3"																					"unprognostic (7.47e-2)"				"unprognostic (1.00e-1)"									"unprognostic (1.11e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2			0.0		50.6	0.0	10.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0										
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 231.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 103.2;REH: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 42.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 42.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favourable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	0.9	13.5	3.5	9.3	5.4	7.6	2.0	1.6	3.4	3.6	1.0	2.9	0.8	0.4	6.0	3.5	3.4	5.0	2.8	0.5	4.7	5.2	2.7	0.3	2.4	25.3	4.9	1.9	1.8	0.8	0.0	1.1	7.8	3.1	2.8	1.0	1.6	3.1	0.7	0.5	2.4	3.9	2.9	4.4	7.0	0.9	8.2	2.3	231.5	2.7	1.3	20.6	4.8	3.2	0.3	0.1	0.5	0.0	8.9	42.2	9.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.8	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	3.2	1.2	0.0	0.0	0.0	4.0	0.6	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.5	0.1	103.2	0.0	0.3	0.2	79.7	1.5	0.0	0.4	0.2	0.5	0.9	0.0	0.0	15.2	0.4	0.0	0.0	2.2	1.8	0.0	2.6	6.7	2.8	18.3	1.3	0.0	8.8	0.0	0.0	0.0	2.6	0.0	0.5	0.1	19.7	8.8	0.0	0.3	42.2	29.2	0.5	8.9	0.0	0.1	25.7	9.5	3.5	5.4	1.6	3.4	4.7	5.2	4.9	1.9	3.1	2.3
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 84.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	Cytosol	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavourable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	6.8	8.8	6.5	24.6	12.7	16.7	7.7	7.7	9.0	8.0	11.3	16.2	7.0	10.6	11.5	8.8	17.7	8.1	6.5	6.2	7.5	5.4	7.0	5.1	7.7	20.4	16.5	6.2	7.7	7.2	9.6	6.3	13.9	8.7	8.2	12.4	8.1	10.5	8.3	7.0	14.8	13.0	8.2	12.7	16.4	9.9	17.2	11.4	84.1	11.4	12.4	24.3	10.9	9.5	5.0	4.8	7.2	2.8	7.8	7.4	3.2	21.9	20.4	21.9	15.8	5.7	6.0	25.6	15.1	12.2	24.6	19.9	18.3	23.3	23.1	4.5	9.9	19.4	36.0	17.7	47.0	41.8	20.2	21.1	23.3	10.4	2.4	26.2	15.3	3.8	6.6	19.2	19.6	16.2	13.4	9.4	21.7	10.9	29.6	17.2	34.2	15.9	25.3	49.8	12.2	8.2	12.3	9.0	9.5	22.6	10.7	8.1	4.7	16.5	10.1	16.2	26.6	10.9	29.4	7.4	9.9	32.9	9.5	15.2	20.0	7.2	2.0	3.6	6.3	2.8	5.6	5.0	6.2	7.3	3.0	3.8	7.4	7.2	1.9	7.8	1.9	4.8	7.2	3.2	6.5	12.7	7.7	9.0	7.5	5.4	16.5	6.2	8.7	11.4
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810902-17844862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 65.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039613	Uncertain									"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	1.4	1.1	0.3	18.0	0.4	12.5	2.5	0.7	0.5	1.4	2.9	0.3	0.2	3.7	0.8	1.2	7.1	0.3	0.7	1.6	0.4	0.7	0.9	1.1	1.8	8.3	2.0	0.3	0.6	0.5	0.0	0.4	3.7	0.5	0.7	2.4	0.3	1.6	0.9	0.6	3.4	3.3	0.7	1.0	6.4	1.9	11.8	0.3	65.4	0.5	6.7	8.6	1.6	2.0	0.5	0.5	0.0	0.4	0.3	2.9	1.7	16.2	10.5	24.0	15.7	1.5	3.0	8.8	21.1	8.3	20.8	21.4	13.3	10.0	24.3	4.3	5.9	7.4	20.3	8.1	28.7	11.0	10.0	19.3	14.3	10.7	0.1	13.6	7.6	0.5	0.5	15.4	7.1	10.4	18.9	27.8	20.6	4.8	15.5	13.2	12.3	10.3	15.4	21.7	10.2	6.3	5.1	18.9	11.2	19.0	4.1	6.0	9.5	7.7	8.5	20.0	9.1	11.3	28.7	8.7	8.1	20.7	8.3	14.2	13.2	0.0	0.0	0.0	0.5	0.2	0.0	0.5	1.0	0.6	0.5	0.2	0.1	0.7	0.0	0.3	0.4	0.0	2.9	1.7	0.3	0.4	0.7	0.5	0.4	0.7	2.0	0.3	0.5	0.3
NFATC3	"NFAT4, NFATX"	ENSG00000072736	"Nuclear factor of activated T cells 3"	Q12968	16	68084751-68229259	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 129.5"	"Cell line enhanced"	"Detected in all"		"HMC-1: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050665			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA050665: AB_2681210"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.28e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-1)"	9.6	6.8	4.3	16.0	6.6	12.0	7.8	7.5	5.8	9.8	11.0	9.7	7.6	7.1	12.2	6.5	7.7	8.3	7.6	7.0	4.7	4.0	8.2	12.1	11.3	14.2	8.7	3.5	10.0	7.0	18.7	6.8	6.6	5.1	10.5	6.1	11.1	7.9	7.6	27.1	14.0	12.0	9.0	6.7	12.3	6.2	25.9	5.8	129.5	11.0	8.1	16.0	10.2	14.1	6.7	3.1	12.0	7.1	13.4	15.6	9.0	4.9	5.8	9.4	10.3	8.4	5.4	8.6	3.2	4.0	9.1	7.9	8.4	4.4	16.5	4.9	5.3	7.4	11.7	5.5	8.9	3.4	7.6	16.2	6.1	18.9	5.6	14.5	42.7	4.1	7.1	9.2	5.0	7.6	20.9	4.7	6.7	9.9	22.3	19.7	6.1	3.1	12.7	9.0	17.0	3.9	5.7	7.1	7.6	24.0	6.1	3.1	8.4	11.0	4.8	4.7	5.1	5.4	4.8	6.5	11.2	30.0	3.6	13.5	6.5	12.0	2.4	5.3	15.6	3.7	14.8	5.2	8.9	15.2	2.9	6.7	9.1	14.0	3.3	13.4	7.1	3.1	6.0	9.0	4.3	6.6	7.5	5.8	4.7	4.0	8.7	3.5	5.1	5.8
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 39.9"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 13.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.6;dendritic cells: 3.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted - unknown location"						"prognostic favourable (4.35e-4)"	"prognostic favourable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favourable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.4	0.3	0.3	38.8	0.3	0.0	0.4	0.3	0.3	0.3	0.9	0.0	0.0	0.3	0.3	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.4	0.4	1.0	39.9	0.3	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.4	1.2	0.1	5.0	0.3	0.3	0.3	7.7	0.0	0.3	18.1	0.6	0.3	0.0	6.6	0.7	0.5	33.0	2.5	0.3	6.6	3.4	1.0	0.2	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.3	0.1	2.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	0.2	0.1	0.1	0.1	6.6	0.1	0.1	0.1	5.6	0.1	0.1	0.4	0.3	0.1	3.4	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.2	28.8	52.0	24.9	1.4	3.2	29.9	31.2	15.8	51.4	36.9	94.6	45.4	41.6	30.6	14.8	38.8	0.2	33.4	52.5	17.7	27.4	12.8	22.1	24.8	0.4	18.3	32.2	1.0	3.6	34.8	34.1	25.0	0.2	35.4	42.3	64.6	30.2	5.2	31.2	69.0	32.1	47.1	0.2	17.3	13.6	30.0	25.0	49.1	36.0	19.7	36.3	27.0	9.1	46.1	40.3	31.3	60.3	11.2	0.3	46.4	28.0	13.1	43.7	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 62.6;REH: 142.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.6	11.3	17.2	12.2	0.5	2.0	2.7	12.7	6.1	13.3	12.9	13.5	7.9	8.9	3.1	5.6	7.8	11.8	6.9	9.4	14.4	13.4	7.7	10.6	14.4	0.2	18.9	11.7	0.9	0.5	7.2	1.8	3.9	11.0	10.3	7.9	12.2	62.6	11.6	7.7	12.3	142.1	38.3	6.5	3.6	11.5	12.7	10.1	10.0	5.5	1.7	9.9	18.1	4.9	14.1	11.5	18.2	15.3	4.4	4.5	26.2	8.1	18.4	17.9	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9										
UMODL1		ENSG00000177398	"Uromodulin like 1"	Q5DID0	21	42062959-42143453	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 22.7"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 3.6;U-266/70: 8.9"	"Group enriched"	"Detected in some"	7	"lung cancer: 0.6;testis cancer: 2.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067245	Uncertain									"HPA067245: AB_2685810"	"unprognostic (4.70e-3)"	"unprognostic (3.75e-5)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.72e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.47e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.82e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-4)"	"unprognostic (2.68e-1)"	0.6	0.1	0.4	3.6	0.1	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	4.9	0.0	0.2	0.2	0.3	0.4	0.4	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.1	0.8	0.2	3.8	0.0	22.7	0.1	0.0	2.0	0.1	0.0	0.5	0.1	0.3	0.5	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.5	0.5	0.0	0.1	0.3	0.7	0.6	0.0	0.0	0.5	0.0	1.0	0.2	0.4	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485061	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 38.1"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 26.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Nucleoplasm, Cytoplasmic bodies"	"Nucleoplasm, Cytoplasmic bodies"	"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	3.3	0.8	0.5	33.4	1.0	3.4	1.2	0.7	0.6	0.8	3.0	0.1	1.0	3.0	0.6	1.2	0.8	0.8	0.9	0.6	0.5	0.7	1.3	0.8	2.0	10.6	0.5	0.0	0.4	0.7	0.0	0.6	0.8	0.5	0.7	1.5	0.9	2.0	0.2	0.4	1.1	7.7	0.4	0.7	9.5	0.7	0.7	0.4	4.8	0.9	1.6	38.1	1.7	0.6	3.2	1.7	1.3	2.7	0.7	7.2	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	6.2	0.1	0.0	0.1	0.0	0.0	0.1	26.4	0.2	0.2	0.8	2.1	0.0	2.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	1.9	0.0	0.0	5.4	0.0	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	3.5	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.3	0.3	2.0	0.1	1.3	1.8	0.4	0.3	1.0	0.5	3.1	3.2	1.5	1.7	3.2	2.0	0.5	1.3	0.7	2.7	1.0	7.2	1.5	0.5	1.0	0.7	0.6	0.5	0.7	0.5	0.0	0.5	0.4
AC119396.1		ENSG00000263264		I3L1I5	19	7348943-7383385	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.2;HL-60: 12.1;HMC-1: 7.7;MOLT-4: 11.7;REH: 10.8;THP-1: 11.7;U-698: 18.3;U-937: 9.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA049151	Uncertain									"HPA049151: AB_2680654"	"unprognostic (7.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-5)"	"unprognostic (7.56e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.55e-2)"	0.5	2.8	0.2	26.7	0.2	13.3	0.4	0.2	0.2	0.7	6.1	0.1	0.0	0.4	6.1	0.3	1.7	0.8	1.9	0.3	0.2	0.2	0.7	0.4	2.0	28.7	0.3	0.5	0.3	0.3	0.0	0.3	0.4	0.1	0.4	0.4	0.4	7.8	0.5	0.3	0.2	9.3	4.0	0.2	21.0	2.9	0.4	0.1	61.5	0.7	0.6	25.9	1.9	0.4	12.1	1.8	15.1	3.9	0.8	4.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	12.1	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	1.7	0.0	0.0	10.8	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.3	0.0	9.6	0.0	1.2	2.4	15.1	2.7	3.0	2.0	7.3	3.8	2.7	1.3	12.1	4.7	3.1	9.9	0.8	3.9	1.8	3.4	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.5	0.1	0.1
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710124	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 430.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.6;HL-60: 2.3;K-562: 3.8;RH-30: 2.4;U-937: 1.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB005067, HPA051210"	Enhanced				"Secreted to blood"	770000	770000			"CAB005067: AB_2071925, HPA051210: AB_2681390"	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	24.4	6.5	0.3	83.5	0.4	0.0	18.0	0.3	0.4	13.6	25.5	0.4	5.9	3.7	26.8	23.7	80.1	23.0	23.2	18.8	0.3	0.0	19.6	11.0	30.5	430.9	0.3	0.3	13.8	3.3	0.0	0.4	7.4	0.5	9.4	11.9	0.7	96.9	4.1	4.7	7.6	71.2	10.6	0.3	35.9	10.7	5.5	0.3	2.3	91.0	44.8	181.2	15.7	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.9	2.4	0.6	0.0	0.0	0.3	0.5	1.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.5	0.0	0.8	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell line enriched"	"Detected in single"	78	"MOLT-4: 64.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdTCR: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favourable (6.33e-4)"	"prognostic favourable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	64.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.3;olfactory region: 21.4"	"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA005565: AB_2078680"	"unprognostic (1.67e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.96e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.97e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.53e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.47e-2)"	1.1	0.6	1.2	28.0	1.5	9.7	1.8	0.5	1.4	8.3	12.3	2.8	2.6	14.9	7.9	1.7	12.9	2.3	6.6	0.9	2.0	1.4	0.8	0.4	1.3	17.2	1.3	2.2	1.1	2.9	0.0	0.4	7.3	3.4	3.2	14.8	1.1	3.3	0.6	4.3	8.3	16.4	1.5	2.0	2.9	7.6	8.1	2.0	71.4	0.9	10.5	24.0	2.3	8.0	2.6	4.2	0.3	0.7	3.6	9.4	2.7	9.8	7.6	17.9	19.4	0.8	3.3	18.7	5.9	2.1	14.2	16.0	11.7	12.5	27.6	7.6	3.6	10.3	28.3	10.7	20.7	13.2	15.6	6.2	5.5	14.8	0.9	40.3	5.9	2.7	0.9	7.7	6.4	6.4	14.9	6.3	4.1	7.9	61.8	40.7	21.1	5.3	43.7	13.6	17.5	6.8	8.7	5.2	9.2	9.3	3.1	5.0	0.0	15.9	2.9	9.3	4.0	3.0	10.9	1.7	3.7	38.7	5.8	22.5	7.8	0.0	0.7	0.0	1.4	0.0	0.5	2.6	3.9	7.6	4.2	0.3	0.3	1.4	0.3	3.6	0.0	0.6	9.4	2.7	1.2	1.5	0.5	1.4	2.0	1.4	1.3	2.2	3.4	2.0
CEP128	"C14orf145, C14orf61"	ENSG00000100629	"Centrosomal protein 128"	Q6ZU80	14	80476983-80959517	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 61.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 25.2;MOLT-4: 21.6;U-266/70: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.6;T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000602, HPA001116, HPA018498"	Uncertain		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite"	"Centriolar satellite"	"HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560"	"unprognostic (6.13e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.48e-1)"	3.8	2.0	5.2	6.5	7.6	10.5	7.5	13.6	5.4	3.4	3.6	4.2	2.7	3.2	4.0	2.2	4.4	4.8	2.0	3.1	3.8	2.5	2.4	2.0	3.8	8.1	6.9	3.1	4.4	2.1	4.2	8.6	2.3	4.5	2.9	3.3	2.3	4.5	3.2	3.1	5.1	3.0	4.0	5.5	6.3	3.1	9.0	6.8	61.2	5.7	3.1	9.1	6.0	4.4	2.2	8.6	1.7	0.8	1.1	9.6	0.8	5.9	3.1	2.8	2.3	0.6	1.1	1.5	6.7	2.0	3.9	3.9	2.1	3.4	13.7	1.2	1.9	3.2	3.0	1.9	7.5	7.7	1.9	2.6	3.9	1.1	0.3	2.7	3.5	0.2	0.5	5.6	3.0	2.9	3.3	25.2	3.7	3.7	21.6	1.4	2.1	3.9	3.9	6.9	10.7	0.8	3.1	3.6	1.7	5.4	2.2	1.1	2.5	2.0	2.7	8.6	4.7	2.3	6.5	45.6	1.8	6.1	2.4	3.6	2.9	0.0	0.8	1.7	2.9	0.3	2.3	2.2	3.2	2.2	2.5	0.9	2.8	1.3	0.1	1.1	0.5	8.6	9.6	0.8	5.2	7.6	13.6	5.4	3.8	2.5	6.9	3.1	4.5	6.8
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"	"Centriolar satellite, Cytosol"	"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.52e-6)"	"prognostic unfavourable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.0	14.7	38.8	17.4	0.9	3.9	12.0	21.5	14.2	31.9	30.4	12.0	20.5	21.6	11.9	12.5	23.1	24.8	17.3	41.9	25.9	12.2	22.1	13.8	10.3	0.1	21.6	13.6	0.7	0.6	14.9	7.2	35.1	17.9	21.6	29.6	17.8	27.3	11.1	20.0	15.4	21.3	37.5	9.9	10.4	12.1	19.8	11.1	22.9	8.6	8.5	19.3	8.1	13.6	14.3	37.4	13.8	24.7	5.3	11.5	28.6	10.0	15.4	22.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2
H2BFS		ENSG00000234289	"H2B histone family member S"	P57053	21	43565189-43565648	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.0"	"Cell line enhanced"	"Detected in many"		"K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				1.1	0.9	0.2	7.4	0.3	1.8	2.6	0.3	0.8	1.8	1.7	0.4	1.1	2.3	2.4	4.3	4.9	4.2	4.2	4.9	0.5		0.5	4.0	3.3	12.2	0.1	0.5	2.2	4.2	0.0	0.0	4.5	0.4	5.3	1.8	0.8	3.0	2.1	1.0	0.4	3.0	1.8	0.7	5.7	2.0	7.9	0.0	65.0	2.6	7.1	6.1	2.1	1.3	7.7	6.2	16.0	4.9	1.6	3.6	3.2	2.0	3.2	0.6	0.9	2.2	0.8	2.3	2.5	1.3	3.2	1.9	4.5	1.0	0.5	8.6	0.8	2.4	0.2	0.7	0.9	2.1	3.5	0.5	4.9	0.2	0.3	0.9	4.4	2.4	0.4	0.6	0.0	0.3	23.2	2.7	0.8	6.0	1.0	2.2	0.3	2.6	0.8	0.5	8.5	0.6	0.7	3.4	2.4	10.2	3.1	2.0	10.9	1.4	0.9	1.7	22.9	1.1	0.6	7.4	23.3	4.9	1.1	11.6	1.0	10.0	2.1	15.0	1.2	2.2	1.0	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16.0	1.6	4.9	6.2	3.6	3.2										
HES3	bHLHb43	ENSG00000173673	"Hes family bHLH transcription factor 3"	Q5TGS1	1	6244192-6245578	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 6.8"	"Cell line enriched"	"Detected in some"	7	"NTERA-2: 15.7"	"Cancer enriched"	"Detected in single"	28	"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	30	"cerebellum: 39.0"	"Low region specificity"	"Detected in many"			"HPA047927, HPA072697"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047927: AB_2680213, HPA072697: "															"unprognostic (7.42e-2)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0
HIST1H2AE	"H2A.1, H2A/a, H2AFA"	ENSG00000277075	"Histone cluster 1 H2A family member e"	P04908	6	26216975-26217483	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 139.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 26.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	0.3	1.8	0.9	19.1	0.9	13.5	33.8	4.9	6.2	3.7	3.8	0.2	3.2	2.8	2.2	13.6	7.2	3.0	2.4	2.2	0.5		0.8	1.5	1.9	11.4	0.0	3.0	2.0	1.1	0.4	0.0	2.9	0.5	10.6	1.6	1.4	2.7	2.5	0.1	2.4	3.4	2.0	3.5	5.9	2.0	5.1	0.0	139.6	2.0	7.4	11.4	2.3	0.0	6.1	15.4	11.4	2.1	4.0	4.2	10.1	2.8	0.0	2.1	0.0	3.5	0.7	0.5	0.9	1.4	3.1	2.1	1.4	2.3	0.1	7.7	0.3	2.3	1.0	1.4	1.2	3.0	2.5	1.8	4.1	1.7	0.6	0.2	2.9	6.1	0.7	1.3	0.1	1.5	7.6	2.1	0.2	5.1	6.2	5.4	2.5	2.6	5.0	1.7	9.8	1.3	1.6	8.5	3.6	7.6	2.6	1.7	10.5	2.8	0.0	0.1	0.6	1.3	1.2	26.4	0.0	0.0	1.1	3.7	1.8	11.4	2.0	6.3	2.7	2.1	3.8	4.3	3.0	4.2	5.0	6.1	1.6	2.1	9.4	4.0	1.2	15.4	3.6	10.1										
HIST1H2BD	"H2B/b, H2BFB"	ENSG00000158373	"Histone cluster 1 H2B family member d"	P58876	6	26158146-26171349	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 174.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 36.8;U-266/84: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	7.9	6.6	6.0	33.2	9.0	36.4	17.3	14.0	8.9	33.6	17.0	2.9	13.2	8.2	9.5	21.4	18.2	17.4	11.1	17.4	7.5	4.2	19.9	25.3	13.8	32.3	7.7	7.1	33.1	21.7	2.2	11.5	10.1	7.4	43.4	12.9	8.3	13.0	14.7	12.0	14.7	9.5	13.0	18.7	11.0	18.8	7.1	5.6	174.9	9.5	23.9	18.9	13.2	32.7	15.6	12.9	19.3	4.5	6.8	9.6	2.0	5.3	12.1	3.7	2.1	29.0	2.6	1.1	4.7	2.7	6.1	3.8	4.0	4.4	2.4	29.8	5.6	8.5	2.0	2.0	2.9	10.9	5.2	1.6	9.7	4.2	3.1	2.1	4.6	19.0	3.2	1.7	2.4	1.5	16.7	13.4	1.1	19.1	4.8	5.4	3.9	5.6	1.9	2.3	15.8	5.8	3.8	11.9	5.0	29.6	7.8	4.6	19.6	0.7	0.9	7.7	19.9	3.1	1.0	36.8	38.8	6.1	0.9	9.9	1.5	19.3	1.5	10.5	5.8	3.4	7.4	8.4	8.9	9.6	3.7	15.6	8.4	5.7	16.6	6.8	4.5	12.9	5.8	2.0	6.0	9.0	14.0	8.9	7.5	4.2	7.7	7.1	7.4	5.6
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell line enhanced"	"Detected in many"		"K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.7	4.7	1.4	1.3	7.1	0.5	1.8	2.1	1.2	8.3	3.6	4.0	2.2	0.6	6.7	2.2	2.7	2.0	1.8	4.6	4.4	3.5	1.1	5.3	0.2	0.6	0.4	3.0	3.4	0.2	1.7	0.8	0.4	41.2	24.3	2.2	2.0	1.7	2.4	1.7	4.4	0.9	1.2	3.7	1.0	1.4	9.2	1.0	37.1	2.5	1.0	0.1	1.5	1.0	2.1	41.1	1.6	0.9	35.0	43.1	9.9	0.5	11.6	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2
HIST1H2BK	"H2BFAiii, H2BFT"	ENSG00000197903	"Histone cluster 1 H2B family member k"	O60814	6	27146418-27146798	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 243.8"	"Cell line enhanced"	"Detected in many"		"K-562: 115.0;U-2 OS: 104.9;U-266/84: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	9.4	6.0	3.0	39.8	4.1	7.8	8.6	2.4	3.6	14.9	11.0	2.5	10.5	8.4	8.0	14.6	19.1	13.5	10.5	9.8	4.3	3.7	4.0	19.3	12.7	25.9	3.6	2.3	8.5	17.4	0.6	5.9	18.7	2.0	16.0	5.3	3.5	11.3	10.7	3.7	6.3	10.3	6.9	7.6	28.0	13.7	30.6	1.9	243.8	8.9	32.3	26.4	11.5	16.7	26.5	22.1	60.7	16.2	5.0	11.5	12.5	6.1	15.9	2.5	4.4	11.5	4.3	8.8	10.1	7.3	14.7	9.5	14.4	8.1	2.0	34.4	5.8	8.1	3.1	3.1	2.2	9.1	15.4	3.4	10.0	0.4	5.0	2.7	20.9	20.6	2.7	2.5	2.8	3.0	115.0	23.3	6.6	16.8	4.9	4.9	2.3	6.9	3.2	1.7	25.9	5.5	2.7	12.9	7.4	60.5	20.8	5.5	53.7	3.1	3.3	6.6	104.9	6.1	1.7	32.0	137.9	18.3	3.8	27.4	3.7	33.8	9.4	60.7	4.1	8.3	3.9	20.3	4.2	4.1	9.6	26.5	5.0	3.9	60.1	5.0	16.2	22.1	11.5	12.5	3.0	4.1	2.4	3.6	4.3	3.7	3.6	2.3	2.0	1.9
HIST1H4E	"H4/j, H4FJ"	ENSG00000276966	"Histone cluster 1 H4 family member e"	P62805	6	26204552-26206038	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 7.4;U-266/70: 14.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (8.62e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.08e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (2.00e-6)"	"unprognostic (1.28e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	2.2	4.8	2.4	5.4	6.8	13.0	4.6	15.1	17.3	7.3	4.7	5.2	5.1	7.4	4.9	6.6	5.2	6.5	5.0	5.1	2.0		3.0	1.9	2.6	5.1	1.3	5.7	11.2	1.6	2.5	2.6	4.7	2.4	10.5	5.0	6.7	7.5	4.6	1.8	2.2	4.6	6.5	2.0	4.9	4.8	7.7	1.8	71.9	6.5	2.7	7.7	7.8	0.0	10.4	5.1	4.8	8.0	3.7	5.9	2.1	1.3	0.9	1.7	3.9	0.6	0.0	0.9	1.5	0.4	0.7	0.5	0.5	1.4	0.5	2.0	0.4	2.4	0.8	0.1	1.0	1.1	1.0	0.4	1.6	0.8	0.0	0.6	1.6	0.4	0.1	0.6	0.4	0.5	2.8	3.3	0.2	0.5	7.4	3.5	1.6	1.3	3.3	1.8	3.3	0.6	0.5	4.8	1.2	1.1	1.6	0.5	1.5	0.7	0.7	2.0	2.7	0.6	1.2	14.6	5.6	2.1	0.4	1.4	1.4	3.2	3.7	2.9	3.8	3.1	5.3	3.9	5.5	3.6	5.1	10.4	5.9	4.5	4.8	3.7	8.0	4.7	3.3	2.1										
HIST3H2BB		ENSG00000196890	"Histone cluster 3 H2B family member b"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 56.0"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	2.0	4.7	1.2	12.1	3.1	2.8	1.3	12.8	3.2	8.9	1.3	1.1	0.6	2.1	1.4	2.0	4.1	6.2	1.7	2.2	1.5	2.2	1.3	0.9	2.1	5.4	1.2	1.5	1.6	1.7	1.7	2.0	1.5	4.1	2.2	1.5	3.4	2.0	2.0	1.8	4.8	1.7	1.2	6.2	4.5	2.4	2.1	0.7	56.0	1.7	5.9	11.8	2.0	7.9	1.5	1.1	3.4	1.5	1.1	0.9	0.5	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.5	1.0	0.1	0.1	0.0	2.5	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.3	0.4	0.1	0.4	0.2	0.0	0.0	0.8	0.0	0.2	1.4	0.5	0.9	0.4	0.3	3.7	0.1	0.1	0.0	0.0	0.5	0.1	18.1	4.3	0.0	0.2	0.1	0.1	1.7	1.0	0.5	0.5	0.5	0.7	1.3	0.8	0.9	0.2	1.5	0.9	0.7	3.4	1.1	1.5	1.1	0.7	0.5	1.2	3.1	12.8	3.1	1.5	2.2	1.2	1.5	4.1	0.7
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 68.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.1;HEL: 9.0;HMC-1: 9.2;Karpas-707: 23.5;U-266/70: 9.1;U-266/84: 13.5;U-937: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favourable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.8	1.7	4.0	24.5	8.5	12.0	2.7	2.4	3.1	1.9	2.3	1.0	0.0	2.2	1.7	2.0	2.5	3.5	3.6	4.3	2.7	2.8	3.8	2.0	8.4	68.3	7.5	0.0	11.0	2.0	0.4	2.3	4.1	5.3	3.0	2.4	1.6	6.1	1.5	0.7	1.3	9.5	2.5	8.4	36.1	3.2	1.8	5.8	20.9	3.4	1.7	28.8	5.3	2.4	7.4	4.5	16.9	9.6	8.4	15.0	6.8	0.1	0.3	0.3	1.0	0.4	1.4	0.2	0.5	0.0	0.0	0.1	0.0	0.9	0.4	1.9	0.4	0.1	0.0	0.2	0.0	20.1	0.0	9.0	0.0	0.8	0.7	0.0	9.2	5.0	0.2	0.0	0.0	0.2	0.0	23.5	0.0	0.4	3.6	0.0	0.1	0.7	4.6	0.0	0.4	0.5	0.0	0.0	0.3	0.1	0.2	0.0	2.0	1.3	0.4	0.0	0.4	0.0	0.0	9.1	13.5	2.5	0.1	13.7	0.2	1.2	4.9	0.2	12.6	9.6	14.5	6.5	15.0	13.1	4.5	7.4	14.9	13.0	16.9	8.4	8.8	3.7	11.8	6.8	4.0	8.5	2.4	3.1	2.7	2.8	7.5	0.0	5.3	5.8
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 25.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;U-266/84: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"					"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.4	0.1	0.2	25.3	0.6	1.1	0.1	1.3	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.1	0.3	0.4	2.0	7.2	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.0	0.6	0.4	0.2	2.4	0.5	0.3	0.2	2.8	0.2	0.3	10.0	0.4	6.0	0.0	11.2	0.2	0.5	17.5	0.7	0.1	0.2	0.0	0.5	0.6	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.5	0.1	0.6	0.0	0.1	0.0	0.2	0.6	1.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577400	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"				Cytosol	Cytosol	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	0.2	0.4	0.0	20.1	0.1	2.8	0.0	0.0	0.2	0.4	1.3	0.0	0.2	1.2	1.0	0.1	1.0	0.0	1.8	0.8	0.0		0.6	0.5	6.0	11.2	0.2	0.0	0.1	1.5	0.0	0.0	0.6	0.2	0.9	0.7	0.9	2.7	0.2	0.5	0.0	2.4	0.1	0.0	10.5	1.4	0.0	0.0	27.0	0.4	1.1	18.1	1.6	1.0	1.0	0.0	2.6	0.0	4.7	4.1	3.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	0.0	0.0	12.9	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	5.4	13.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	3.3	0.4	0.2	0.0	0.2	0.1	0.3	0.0	19.9	0.1	9.7	0.0	2.6	0.0	0.0	3.7	0.0	4.1	1.0	2.7	3.8	0.0	0.8	2.1	2.0	0.0	4.7	0.0	0.0	3.1	3.3										
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444415-6451469	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.3"	"Cell line enhanced"	"Detected in many"		"AF22: 49.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	1.9	4.5	1.2	1.6	1.1	3.1	2.2	1.0	0.8	1.3	4.7	0.6	0.4	4.3	1.6	1.7	6.0	0.3	2.5	1.6	0.5	0.5	0.8	0.9	2.1	1.7	0.6	0.4	1.6	0.4	0.0	1.0	0.9	1.2	0.8	6.2	0.4	1.3	0.4	0.4	3.7	4.5	2.7	1.0	9.5	1.8	1.0	0.4	27.3	0.4	3.9	3.6	2.3	2.0	0.4	0.0	0.8	0.4	3.3	1.5	1.2	12.4	16.8	49.8	22.3	0.4	1.4	3.9	14.6	9.0	24.0	16.2	9.9	5.4	0.0	5.8	11.8	9.1	25.1	6.5	12.9	19.2	10.0	0.0	10.0	12.0	0.0	0.5	15.2	0.7	0.4	9.9	3.9	7.5	2.9	7.1	15.0	8.9	2.7	0.1	21.8	11.0	22.3	20.0	8.7	3.9	1.9	11.3	15.9	12.6	13.2	12.3	6.1	1.2	3.5	18.8	15.3	11.0	23.8	2.5	9.0	0.0	7.3	6.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	0.4	0.2	0.7	0.8	3.3	0.4	0.0	1.3	1.2	1.2	1.1	1.0	0.7	0.5	0.5	0.6	0.4	1.2	0.4
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"									HPA056994	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.1	17.7	25.0	17.1	2.2	4.1	24.8	47.7	23.6	34.1	37.1	29.5	14.0	26.8	6.6	14.9	14.3	40.5	24.6	41.8	60.0	15.6	51.6	17.0	26.0	0.1	38.2	24.8	1.4	0.5	41.7	3.5	27.5	21.6	79.5	42.4	22.0	42.2	20.5	20.2	20.7	31.8	54.6	18.4	16.7	22.2	24.8	20.4	39.2	27.9	4.8	15.0	6.9	9.6	26.1	38.0	19.5	66.8	51.6	40.5	54.7	18.5	32.4	37.5	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186292	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA035501: AB_2732469, HPA069302: , HPA069857: "	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.6	0.6	0.4	9.1	0.4	8.9	1.0	0.4	1.5	0.9	3.4	0.3	0.6	2.7	0.8	0.5	4.0	0.3	1.7	0.4	0.3	0.4	0.8	1.0	0.9	6.9	0.4	0.1	0.5	0.5	0.0	0.4	3.7	0.2	0.6	3.5	0.1	1.0	0.1	0.3	1.1	3.4	0.8	0.4	4.9	1.5	8.6	0.2	40.1	0.5	2.4	7.4	1.2	1.5	9.0	4.5	8.3	0.2	0.3	2.7	0.6	9.4	10.8	14.7	9.0	0.7	1.3	10.0	10.2	5.2	14.9	16.3	7.6	11.7	14.5	5.1	4.2	5.5	13.9	5.6	18.8	18.4	9.2	16.4	7.4	6.1	0.1	14.9	14.2	0.1	0.4	16.3	6.9	8.8	14.0	25.9	12.3	9.3	23.4	8.4	15.7	8.2	15.0	18.9	8.4	3.7	6.9	7.3	7.7	11.2	13.9	6.7	9.0	10.5	2.4	11.3	13.5	10.0	20.3	11.1	25.9	16.8	6.2	15.1	16.9	8.3	0.1	1.5	0.3	0.2	0.1	8.6	0.7	0.8	0.4	9.0	0.2	0.4	1.6	0.3	0.2	4.5	2.7	0.6	0.4	0.4	0.4	1.5	0.3	0.4	0.4	0.1	0.2	0.2
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 163.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 23.7;Karpas-707: 53.2;MOLT-4: 63.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdTCR: 27.3;MAIT T-cell: 36.5;memory CD4 T-cell: 20.6;memory CD8 T-cell: 40.1;naive CD4 T-cell: 21.0;naive CD8 T-cell: 25.2;NK-cell: 31.7;T-reg: 25.3"	"Group enriched"	"Detected in many"	67	"NK-cells: 31.7;T-cells: 40.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	2.5	0.5	0.4	5.8	0.6	2.5	1.0	0.2	0.3	0.8	1.0	0.4	0.5	0.6	0.7	0.8	0.9	0.6	2.6	0.6	0.5	0.4	1.1	1.7	4.1	21.3	0.6	0.2	0.6	0.3	0.0	0.4	0.4	0.3	1.0	0.7	0.7	1.9	0.3	0.3	0.4	4.0	0.3	1.0	12.2	1.3	0.4	0.3	163.1	1.3	0.7	10.2	4.2	1.1	0.2	0.1	0.5	0.2	31.7	40.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.2	0.0	0.0	63.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	8.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	27.3	0.1	36.5	0.2	20.6	40.1	0.1	0.0	21.0	25.2	0.5	31.7	0.2	0.1	25.3	17.2	0.4	0.6	0.2	0.3	0.5	0.4	0.6	0.2	0.3	0.3
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608100-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 97.8"	"Cell line enriched"	"Detected in single"	111	"HDLM-2: 57.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.1"	"Group enriched"	"Detected in many"	10	"B-cells: 8.8;T-cells: 24.1"									"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	590000	590000			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"	2.5	0.3	0.3	14.2	0.3	4.4	1.4	0.2	0.3	1.2	2.3	0.4	0.5	2.2	0.5	1.2	2.2	0.8	2.3	1.3	0.2	0.2	2.0	1.0	4.0	14.8	0.2	0.1	0.6	0.9	0.0	0.5	2.3	0.3	1.1	2.1	0.6	4.1	0.6	0.8	1.1	7.6	1.0	0.5	10.6	2.4	0.4	0.2	97.8	1.5	1.9	26.3	3.5	1.1	8.8	1.6	0.2	0.1	0.0	24.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.1	0.0	4.2	0.0	24.1	6.2	17.2	12.1	0.1	8.8	6.6	1.6	0.2	0.0	0.0	1.6	21.5	3.5	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.1	0.3	0.2
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HAP1: 24.5;MOLT-4: 9.6;NTERA-2: 50.3;REH: 10.5"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003629	Approved									"HPA003629: AB_2190964"	"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	50.3	0.0	10.5	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25, NDC80 kinetochore complex component"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 38.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.1;T-cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"HPA047144: AB_2679952, HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (4.74e-6)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.9	1.6	3.6	7.2	2.2	6.7	2.1	0.4	3.5	1.3	4.0	0.9	0.0	6.8	1.3	1.5	8.5	0.6	1.0	1.1	2.7	1.6	1.5	1.6	1.9	7.5	1.2	2.5	1.2	2.6	0.7	0.2	3.3	1.1	0.8	3.1	1.3	2.1	0.0	0.7	2.1	3.8	1.8	0.7	4.1	3.0	5.9	1.1	38.0	0.6	5.6	8.0	1.5	2.7	1.1	0.0	0.4	0.1	0.0	2.5	0.4	1.0	8.4	19.5	10.9	0.9	0.9	7.0	11.2	4.3	11.3	9.1	4.3	7.8	6.9	4.9	1.8	10.4	7.5	0.0	10.1	4.7	11.5	13.9	5.3	1.9	0.0	10.3	4.2	0.0	0.5	7.2	0.1	5.7	1.1	7.9	3.2	5.1	7.5	12.5	0.6	11.2	13.5	19.4	3.1	4.5	6.6	14.6	0.9	10.0	6.8	1.8	0.5	7.3	1.6	1.7	20.6	6.6	9.4	15.2	26.5	6.9	2.2	1.6	6.6	0.0	0.1	0.2	0.0	0.1	0.0	0.9	0.4	0.0	0.0	1.1	0.2	0.5	0.4	0.0	0.0	0.0	2.5	0.4	3.6	2.2	0.4	3.5	2.7	1.6	1.2	2.5	1.1	1.1
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 109.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.8;MOLT-4: 29.3;RPMI-8226: 12.5;U-266/70: 5.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.1"	"Group enriched"	"Detected in many"	23	"gdTCR: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2"	"Lineage enriched"	"Detected in single"	88	"T-cells: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031422, HPA031425"	Enhanced									"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	1.4	0.6	1.9	9.6	0.8	2.4	0.8	0.2	7.1	1.0	2.8	0.1	0.5	2.2	0.9	0.9	1.2	0.8	2.4	0.5	1.8	0.6	0.9	0.9	3.6	13.2	1.1	0.1	0.9	0.6	0.0	0.4	0.2	0.5	0.9	1.3	0.8	5.2	0.9	0.3	0.5	5.0	0.8	1.5	5.8	2.0	0.4	0.4	109.6	1.3	1.6	10.4	2.3	1.2	0.0	0.0	0.2	0.0	0.0	25.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	14.5	0.0	14.5	20.5	0.0	0.0	13.1	25.2	0.2	0.0	0.0	0.0	0.7	7.4	1.9	0.8	0.2	7.1	1.8	0.6	1.1	0.1	0.5	0.4
TMEM26	"Em:AC068892.1, MGC35010"	ENSG00000196932	"Transmembrane protein 26"	Q6ZUK4	10	61406643-61453450	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 30.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.1;fHDF/TERT166: 2.2;HSkMC: 3.9;HUVEC TERT2: 2.9;MOLT-4: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 2.7"	"Low region specificity"	"Detected in many"														"unprognostic (1.21e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.34e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.29e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.95e-1)"	1.3	1.2	3.7	1.0	2.1	0.0	7.4	0.3	2.0	3.2	1.1	0.9	1.1	1.8	5.6	0.9	0.6	0.8	1.2	0.6	0.9	1.0	3.6	4.5	1.8	5.8	1.5	1.3	2.1	0.4	5.6	0.7	1.8	1.1	3.5	1.1	3.6	0.5	3.2	0.7	0.3	1.9	2.5	0.9	30.2	0.5	4.4	1.2	6.2	0.7	0.2	0.1	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.2	0.0	9.1	1.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.9	0.0	1.0	0.0	2.9	0.0	0.0	0.3	0.0	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	2.1	0.3	2.0	0.9	1.0	1.5	1.3	1.1	1.2
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805418-59119208	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 88.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 9.8;MOLT-4: 53.9;SH-SY5Y: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	1.3	1.2	10.5	15.7	6.3	2.8	1.5	1.9	15.6	2.1	13.4	1.5	1.2	10.0	1.5	1.1	3.7	1.1	5.0	0.9	6.3	9.8	3.2	1.7	4.9	17.7	4.8	12.0	6.6	2.4	2.9	3.7	1.5	2.2	2.4	9.3	2.6	1.8	1.3	0.5	1.0	10.7	2.8	2.3	5.7	10.0	6.5	2.5	88.8	1.5	0.8	19.4	2.6	2.3	3.4	0.8	10.2	0.1	10.4	21.0	3.1	0.3	0.0	6.0	0.0	0.6	1.4	0.0	1.2	2.8	0.7	0.1	0.0	0.0	0.0	0.0	5.4	0.4	1.4	0.0	0.1	0.2	0.5	0.0	1.1	0.0	5.0	1.0	0.2	0.7	0.2	0.9	1.1	9.8	0.0	0.0	0.4	0.0	53.9	0.0	1.0	0.1	1.1	4.1	0.0	0.1	0.1	5.5	16.9	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.7	4.9	1.6	0.0	0.0	3.7	0.2	0.0	1.0	10.2	0.1	1.8	7.5	0.0	3.4	3.4	5.5	11.3	0.8	0.6	2.1	6.3	0.2	10.4	0.0	0.0	21.0	3.1	10.5	6.3	1.9	15.6	6.3	9.8	4.8	12.0	2.2	2.5
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2, microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 92.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"				Nucleoplasm	Nucleoplasm	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (8.07e-7)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.8	1.7	1.0	13.4	2.0	21.7	1.2	2.2	1.7	2.2	5.7	0.5	0.3	4.6	1.2	2.3	13.3	0.5	1.9	1.5	0.8	0.7	1.2	2.7	2.6	12.9	0.7	1.1	0.8	0.5	0.0	0.7	6.6	0.9	0.7	7.4	0.5	2.3	0.5	2.2	5.9	4.7	3.2	0.9	5.9	3.2	22.0	0.6	92.7	0.7	11.0	16.2	2.2	3.8	1.0	1.4	4.0	0.1	4.8	10.4	1.3	69.6	23.4	28.3	22.1	2.2	4.2	27.3	29.3	16.6	42.6	32.2	49.6	30.1	32.8	17.3	16.3	36.8	32.3	26.6	48.6	14.1	12.5	64.3	22.4	33.8	0.7	24.6	16.6	1.4	1.4	26.7	19.5	22.9	47.5	30.0	33.3	28.6	41.2	19.2	31.5	25.3	23.4	76.4	19.8	11.4	11.4	20.6	13.8	44.8	17.0	13.2	29.5	15.0	15.4	47.8	29.4	21.9	44.9	12.0	20.7	29.4	14.9	87.9	31.0	4.0	0.0	0.5	0.6	0.0	0.3	1.0	1.9	2.3	0.6	0.4	0.4	0.7	0.4	4.8	0.1	1.4	10.4	1.3	1.0	2.0	2.2	1.7	0.8	0.7	0.7	1.1	0.9	0.6
